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ABSTRACT 
 
This dissertation includes three studies that examined the impact of inadequate sleep 
duration in adolescents and young adults on asthma and systemic inflammation. We used data 
from the Florida Youth Risk Behavior Survey (YRBS), years 2009-2013, and from the National 
Longitudinal Study of Adolescent to Adult Health (Add health), which was conducted between 
1994 and 2008.  
The first study used data from 16,738 high school students participating in the Florida 
YRBS. We examined the cross-sectional association between sleep duration and asthma, and the 
interactive effects of sleep duration and BMI. We found that short and long sleep durations were 
associated with increased odds of current asthma. Compared with 7-8 hours of sleep per night, 
sleeping for <7 hours had an OR (95% CI) of 1.22 (1.07, 1.40), while sleeping for ≥ 9 hours had 
and OR of 1.31 (1.06, 1.63). We found a significant effect modification by BMI, with the 
associations between sleep duration and asthma mostly limited to overweight adolescents. 
Compared with normal weight students who sleep for 7-8 hours per night, those who are 
overweight and sleep for <7 hours or ≥ 9 hours have approximately twice the odds of having 
current asthma [OR= 1.75 (1.45, 2.11), and OR=2.00 (1.32, 3.02) respectively]. No significant 
associations were found in normal-weight adolescents.  
The second study used data from 12,633 adolescents (age 13-19) participating in the 
National Longitudinal Study of Adolescent to Adult Health (Add health), and followed through 4 
waves of interviews through their young adulthood (age 24-32). We constructed trajectories of 
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sleep duration through 4 waves of data for participants without asthma at wave I (n=11,016), and 
examined the association between sleep duration and the risk of asthma by young adulthood. 
Similarly, we constructed trajectories of sleep duration for participants with asthma at wave I 
(n=1,395) through 3 waves of data, and examined the association between sleep duration and 
persistence of asthma into young adulthood.  Sleep trajectories in non-asthmatic participants 
showed that 13.8% of them had persistent short sleep duration, while 80.7% had adequate sleep 
durations from adolescence though young adulthood. Those with consistently short sleep had 
1.59 times the risk of new onset asthma by age 32 (95% CI 1.12, 2.26), compared with 
consistently adequate sleepers. Among adolescents with asthma, 10.2% had consistently short 
sleep through age 24, while 81.2% had adequate sleep. Short sleepers were 2.35 times more 
likely than adequate sleepers to have their asthma symptoms persist into young adulthood (95% 
CI 1.12, 4.96).  
 The third study used data from waves III and IV of the Add health study, and examined 
the association between sleep trajectories over a 6-year follow-up in young adulthood, and the 
risk of elevated high sensitivity C-reactive protein (hs-CRP), a marker of systemic inflammation. 
Short sleep trajectories were associated with a significant increase in log-transformed hs-CRP 
(coefficient=0.11, p-value 0.03), and with a significant increase in the odds of having hs-CRP 
levels >3 mg/dl (OR=1.85, 95% CI 1.29, 2.67). The association was modified by sex, with the 
association between short sleep duration and hs-CRP limited to males. In males, both the 
continuous (coefficient 0.117, p-value=0.0362) and the categorized hs-CRP (OR= 2.21, 95% CI 
1.48, 3.30) were significantly increased with short sleep durations, while no significant 
associations were seen in females with short sleep durations. By contrast, there was a significant 
increase in log hs-CRP in females with long sleep durations (coefficient=0.232, p-value=0.0296), 
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and a non-significant increase in the odds of having hs-CRP levels greater than 3 mg/dl 
(OR=1.48, 95% CI 0.75, 2.93), while there were no associations with long sleep duration in 
males.  
 The results of this dissertation research point to the detrimental effects of sleep loss on the 
bodies of adolescents and young adults. We found sleep loss to be associated with the incidence 
of asthma and its persistence, in addition to heightened systemic inflammation, which is a likely 
pathway that links sleep duration with the above outcomes. Our findings indicate that males are 
more susceptible to the effect of insufficient sleep on the risk of heightened inflammation, while 
females are more susceptible to the effects of long sleep durations. Interestingly, adolescents in 
the more recent YRBS study had shorter sleep durations than those who participated in the earlier 
Add health study. The prevalence of sleeping less than 7 hours was 16.5% in the add health study 
(years 1994-1995), compared with 47.2% in the YRBS study (years 2009-2013), indicating a 
progressive decrease in the average sleep duration of adolescents. 
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SECTION 1 
 INTRODUCTION 
“What people need to know is that asthma isn't a minor 'wheeze-disease.' It kills over five thousand 
people in America every year, and I could've been one of them.”        
              -Jackie Joyner-Kersee 
 
Indeed, asthma is not a minor condition; it is common cause of morbidity and mortality in 
the United States and around the world. The prevalence of asthma has been increasing in the past 
few decades, as has the prevalence of obesity and both are causing significant morbidity. Modern 
lifestyle is at least partially responsible for the increase in prevalence of many chronic diseases. A 
life filled with stimulation as a result of technological advancements has a side effect of sleep 
deprivation, which was recently found to be associated with negative health outcomes. Although 
studies show that asthma leads to sleep disruption and poor sleep quality, few studies examined 
the impact of poor sleep quality or quantity on asthma, and their results were inconclusive. Sleep 
loss was found to be associated with systemic inflammation in cross-sectional and some 
longitudinal studies, which is likely to explain the relationship between sleep and many health 
conditions. However, this pathway is yet to be explored in terms of the association between sleep 
duration and asthma.  
In this study, we propose to examine the association between sleep duration and asthma 
using two population-based data sets. We will utilize the Florida Youth Risk Behavior Survey 
(YRBS) to examine the association between sleep duration and asthma in Florida teenagers, and 
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whether BMI modifies this association. Using the National Longitudinal Study of Adolescent to 
Adult Health (Add Health), we will examine the association between trajectories of sleep duration 
from adolescence into young adulthood and the incidence and persistence of asthma, and the 
prevalence of heightened systemic inflammation in young adults, as well as the role of BMI and 
sex-related differences in these associations. The results of this study will pave the way for future 
recommendations and interventions that target sleep duration and quality, in order to reduce the 
impact and morbidity of asthma.  
BACKGROUND AND SIGNIFICANCE 
The prevalence of asthma has been increasing in recent decades, leading to a significant 
impact on the health and well-being of affected individuals, as well as the nation as a whole. In 
2009 –in the USA alone– asthma was responsible for 3,388 deaths; 479,300 hospitalizations; 14.4 
million lost school days in children and 14.2 million lost workdays in adults; and an annual cost 
of $56.0 million.1 Asthma is the most common chronic disease in childhood, affecting 
approximately seven million children in USA.2 The prevalence of asthma has been on the rise. In 
USA, the number of persons with asthma increased between 2001 and 2010 by 2.9% each year, 
from 20.3 million persons in 2001 to 25.7 million persons in 2010. Current asthma prevalence 
increased at a rate of 1.5% per year, to a prevalence of 8.4% in 2010.3 However, the number of 
deaths from asthma declined from 2001 (4,269) to 2009 (3,388) at a rate of 3.3% per year.1 The 
increase in asthma prevalence and its morbidity prompted many studies of the risk factors as well 
as preventive measures that may reduce its morbidity and impact. Studies show that asthma is the 
result of interaction of host and environmental factors that contribute to the development of the 
disease as well as aggravation of its symptoms.4 Obesity recently received much attention as 
potential risk factors for many chronic diseases, including asthma, as it is associated with an 
 
 
3 
 
increased risk of asthma and with poor asthma control.5 Many mechanisms were proposed to 
explain this association, most prominently through the inflammatory pathway.6,7 This pathway has 
also gained a lot of attention recently as a possible explanation of the association between sleep 
loss and obesity, heart disease, and other chronic illnesses.8  
Chronic sleep loss is a prevalent public health problem that, along with other sleep 
disorders, affect as many as 70 million Americans, leading to an annual cost of $16 billion in health 
care expenses and $50 billion in lost productivity.9 Healthy People 2020 includes an objective to 
increase proportion of students in grades 9 through 12 who get sufficient sleep to 33.1%, from a 
baseline of 30.9%, and increase the proportion of adults who obtain sufficient sleep from 69.6% 
to 70.8%.10 Chronic sleep loss is linked with an increased risk of obesity, cardiovascular diseases, 
metabolic syndrome, poor cognitive function, and mortality.11 Systemic inflammation is one of the 
pathways proposed to explain these associations. However, the majority of studies examining the 
association between sleep loss and inflammation have been cross sectional, with few longitudinal 
studies with inconsistent findings.12  
Asthma is associated with poor sleep quality, mainly due to nocturnal symptoms. However, 
even those who do not have nocturnal symptoms still suffer from sleep disturbances,13 and those 
disturbances are associated with worse subsequent symptoms14–17 and quality of life,14,18–21 
suggesting that the association between sleep loss and asthma is in fact bi-directional. 
Experimental evidence of the impact of improved sleep duration on asthma morbidity came from 
a pilot study by Meltzer et al. who found that sleep extension in teens with asthma led to an 
improvement in symptoms and lung function.22 Likewise, Mastronade et al. found that improved 
sleep quality correlated with improvements in asthma control and quality of life.14 Longitudinal 
studies23–26 provided clues into the possible association between sleep loss and asthma, however 
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their methods and results were inconsistent. No longitudinal study to date has examined the impact 
of sleep trajectories from adolescence into young adulthood on the risk or persistence of asthma 
or on the risk of systemic inflammation in young adulthood. 
Adolescents with asthma are a unique population. Adolescence is a period of physical and 
psychosocial changes that affect the health and well-being of teenagers. Overall, adolescents with 
asthma are at increased risk for asthma morbidity and death as the adolescent becomes more 
independent and takes control of his/her asthma management. Non-adherence to medical regimens 
as well as lifestyle factors contribute to the increase in asthma morbidity.27  Moreover, adolescents 
frequently report insufficient sleep.11 Unfortunately, studies of the association between sleep and 
asthma in adolescents and young adults are lacking, and none has looked at the longitudinal effects 
of cumulative sleep loss in adolescence and young adulthood on subsequent systemic 
inflammation and asthma incidence and prevalence in young adulthood. 
This dissertation encompasses three studies that will use different populations and data, 
and aim to shed the light on the association of sleep loss, inflammation, and asthma. The findings 
of this research may pave the way for future studies on sleep-related interventions that may help 
reduce the morbidity of asthma as well as the economic burden associated with it. 
SPECIFIC AIMS AND OBJECTIVES 
The purpose of this study is to evaluate the association between sleep loss and asthma as 
well as inflammation, accounting for the roles of BMI and sex. We plan to attain this goal by 
pursuing the following specific aims:  
Aim 1. To examine the association between sleep duration and asthma in adolescents, and 
whether BMI modifies this association 
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Objective 1.1: To explore the association between sleep duration and the presence of asthma in 
high school students in Florida. 
Hypothesis 1.1: Our hypothesis is that inappropriate sleep duration in adolescents is associated 
with a higher prevalence of asthma than is optimal sleep duration.  
Objective 1.2: To examine whether BMI modifies the above association between sleep duration 
and asthma.  
Hypothesis 1.2: We hypothesize a synergistic interaction between inappropriate sleep duration and 
BMI in explaining prevalent asthma.  
Aim 2. To determine the impact of sleep duration trajectories from adolescence to young 
adulthood on the risk and persistence of asthma in young adulthood. 
Objective 2.1: To examine the association between inappropriate sleep duration trajectories from 
adolescence to young adulthood on the incidence of asthma by age 24-32 in non-asthmatic 
adolescents. 
Hypothesis 2.1: Non-asthmatic Adolescents who have persistent short or long sleep durations are 
more likely to develop asthma by young adulthood (age 24-32) than those with optimal sleep 
duration. 
Objective 2.2:  To examine the association between sleep duration trajectories from adolescence 
into young adulthood and persistence of asthma into young adulthood, in adolescents who have 
asthma,.  
Hypothesis 2.2: Asthmatic adolescents with persistent short or long sleep duration are more likely 
to have their asthma persist into young adulthood (age 18-24) compared with adolescents with 
optimal sleep duration. 
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 Aim 3. To examine the association between sleep duration trajectories and systemic 
inflammation in young adulthood, and the potential interaction with sex.  
Objective 3.1: To quantify the association between sleep duration trajectories throughout young 
adulthood and hs-CRP in young adulthood. 
Hypothesis 3.1: Young adults with short or long sleep duration are more likely to have elevated 
hs-CRP, compared with young adults with optimal sleep duration. 
Objective 3.2: To examine the effect of sex on the association between young adult sleep duration 
trajectories and elevated hs-CRP. 
Hypothesis 3.2: Female young adults with short or long sleep duration are more likely than their 
male counterparts to have elevated hs-CRP in their young adulthood. 
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SECTION 2 
 SLEEP DURATION, OBESITY, AND ASTHMA, IN FLORIDA ADOLESCENTS: 
ANALYSIS OF DATA FROM THE FLORIDA YOUTH RISK BEHAVIOR SURVEY 
(2009-2013) 
 
ABSTRACT  
Purpose: To examine the association between sleep duration and asthma among Florida high 
school students, and determine whether body mass index (BMI( is an effect modifier of this 
association. 
Methods: This is a cross-sectional analysis that included 16,728 high school students, 
participating in the Florida Youth Risk Behavior Survey (2009, 2011, and 2013). We used 
logistic regression to obtain odds ratios (OR) and 95% confidence intervals (CI) of the 
association between sleep duration and current asthma, after controlling for potential 
confounders, followed by analyzing the interaction between sleep duration and BMI.  
Results: Both short and long sleep durations were associated with increased odds of current 
asthma. Compared with 7-8 hours of sleep per night, sleeping for <7 hours had an OR (95% CI) 
of 1.22 (1.07, 1.40), while sleeping for ≥ 9 hours had and OR of 1.31 (1.06, 1.63). We found a 
significant effect modification by BMI, with the associations between sleep duration and asthma 
mostly limited to overweight adolescents. Compared with normal weight students who sleep for 
7-8 hours per night, those who are overweight and sleep for <7 hours or ≥ 9 hours have 
approximately twice the odds of having current asthma [OR= 1.75 (1.45, 2.11), and OR=2.00 
(1.32, 3.02) respectively]. No significant associations were found in normal-weight adolescents. 
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Conclusion: Sleep durations that are too short or too long are associated with asthma in 
adolescents. However, these associations are modified by BMI. Both associations of short and 
long sleep durations with asthma are statistically significant in overweight adolescents but 
weaker and statistically non-significant in those with normal BMI. 
INTRODUCTION  
  The prevalence of asthma has been increasing in recent decades, leading to a significant 
morbidity, mortality, and economic impact.1 Meanwhile, the average sleep duration of Americans 
has declined by 20% in the past century.28 Half of high school students participating in the 2007 
National Youth Risk Behavior Survey reporting short sleep duration (6-7 hours per night), and 
another 14.8% of males and 16.9% of females reporting very short sleep durations (5 hours or 
less).29  
 Asthma is known to be associated with poor quality sleep, mainly due to nocturnal 
symptoms.30 However, its association with sleep duration is less clear. Some studies have found 
that sleep durations among asthmatic adults,31–33 and children34,35 are generally shorter than sleep 
durations in those without asthma, while other studies have not found such differences in 
adolescents22 or children.36,37 Some of these studies relied on parental report of adolescent sleep 
duration, which may not accurately reflect actual sleep duration, as parents tend to report earlier 
bed times and give an idealized version of their adolescents’ sleep habits.38 
 Short or long sleep durations may increase the risk of obesity, which in turn is associated 
with an increase in risk of asthma as well as with poor asthma control. Different mechanisms have 
been proposed to explain these associations including neuroendocrine and hormonal mechanisms, 
as well as activation of chronic inflammatory responses.8 It is therefore possible, at least in theory, 
that inadequate sleep durations may affect the risk and/or outcomes of asthma through the 
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inflammatory pathway. It is also possible that inadequate sleep will interact with obesity to cause 
an even greater increase in the risk of asthma. With the increasing prevalence of overweight and 
obesity, knowing whether those affected are more susceptible to the effects of sleep loss will help 
target interventions and channel resources efficiently. No studies to date have examined the effect 
of sleep duration on asthma and the potential effect modification by BMI.  
The purpose of this study is to examine the association between sleep duration and asthma 
among Florida high school students, and determine whether body mass index (BMI( is an effect 
modifier of this association. 
METHODS  
Population 
The Florida Youth Risk Behavior Survey (YRBS) is statewide, school-based confidential 
survey of Florida’s public high school students, and is administered on odd years with the purpose 
of monitoring priority health-risk behaviors that contribute substantially to the leading causes of 
death, disability, and social problems among youth, which contribute to patterns in adulthood. A 
detailed description of the survey design and instruments can be found at Florida Department of 
Health’s website.39 YRBS uses a two-stage cluster probability sampling design. First, a random 
sample of public high schools is selected for participation in the survey.  Second, within each 
selected school, a random sample of classrooms is selected, and all students in those classes are 
invited to participate in the survey.  The responses of the survey participants are weighted to be 
representative of all Florida public high school students. This analysis uses data from three years 
of YRBS, 2009; 2011; and 2013 
The 2009 survey was completed by 5,664 students with an overall response rate of 71% , 
the 2011 survey was completed by 6,212 students with an overall response rate of 75%, and the 
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2013 survey was completed by 6,089 students, with an overall response rate of 69%. For this 
analysis, we included all participants in the survey, excluding those who had missing values for 
sleep duration or asthma (N=16,626) 
Measures 
YRBS collects data by administering a survey to students. The survey includes 
demographic questions as well as self-reported height and weight, and questions on a variety of 
behavioral, physical activity, dietary, health and sleep topics.  For the purpose of this analysis we 
will include the following measures: 
Sleep duration: Students were asked: “On an average school night, how many hours of 
sleep do you get?” Answer choices included 4 hours or less, 5 hours, 6 hours, 7 hours, 8 hours, 9 
hours, and 10 hours or more. We categorized the responses based on the recommendations of the 
National Sleep Foundation for this age group,40 into short duration (less than 7 hours), normal 
duration (7-8 hours) and long duration (9 hours or more).  Our choice of a lower cutoff for long 
sleep duration (9 hours or more) was based on the low prevalence of long sleepers in our study 
sample (2.1% slept more than 9 hours). 
Asthma: Students were asked two questions related to asthma. “Has a doctor or nurse 
ever told you that you have asthma?” (Yes/No/Not sure), and “Do you still have asthma?” 
(Yes/No/Not sure). For the purpose of this analysis, students who answered “Yes” to both 
questions were considered to have current asthma. 
BMI: The datasets included pre-calculated BMI percentiles based on self-reported height 
and weight. They also included two dichotomous (yes/no) variables labeled “overweight” and 
“obese” for students who meet the cutoff according to the CDC guidelines (overweight: at or 
above 85th percentile for age and sex but less than the 95th percentile, Obese: at or above the 95th 
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percentiles). For the purpose of this analysis, we considered students labeled as “overweight” or 
“obese” to be overweight. We classified students who were neither overweight nor obese to be of 
normal weight. This category also includes underweight teenagers, which account for 3.5% of 
the study population. 
Covariates: 
 Demographic variables: Age (in years), sex, race/ethnicity (Hispanic or Latino, Asian, 
Black or African American, White, Other) 
 Behavioral variables: Smoking (on one or more days in the past 30 days), alcohol use 
(on one or more days in the past 30 days),  marijuana use (on one or more days in the 
past 30 days), and physical activity (Active=60 or more minutes per day at least five 
days a week).  
Data analysis  
Statistical analysis was carried out using SAS 9.4 software, using procedures that 
accommodate the weighted sampling design of YRBS. We combined the three datasets  
according to the CDC  guidelines: 
(http://www.cdc.gov/healthyyouth/yrbs/pdf/yrbs_combining_data.pdf), then checked for missing 
data. We calculated baseline statistics for the whole sample and separately for adolescents with 
current asthma and those without asthma, and used chi-square to test for the difference. Logistic 
regression was used to estimate the strength of association between sleep duration and asthma, 
first with bivariate model, then with multivariate analysis controlling for potential confounders. 
The first model included age, gender, and race. The second model included, in addition to the 
variables included in model 1, behavioral factors (smoking and  marijuana). The third model 
included variables in model 2 in addition to BMI and physical activity, as these may be 
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intervening variables. Model four was similar to model 3 with the addition of the interaction term 
(sleep duration*BMI category) to check for significant interaction. From this model we will 
report odds ratios for each combination of sleep duration and BMI, compared with the reference 
category of normal sleep duration-normal weight. 
RESULTS   
The analysis included 16,626 High school students, 1668 (9.86%) of whom had current 
asthma (Table 2.1). Compared with adolescents without asthma, those with current asthma were 
generally younger, more likely to be female, less likely to be white (42.6% vs. 45.3%, P=0.0175), 
and more likely to use marijuana and drink alcohol. They were also significantly more likely to be 
overweight (30.9% vs. 24.9%, P<0.0001).  
The distribution of sleep duration (Table 2.1) showed that 47% of participants slept for 6 hours or 
less per night, while only 25% got the recommended 8 hours or more of sleep. Sleep duration 
differed significantly between asthmatic and non-asthmatic teenagers (P<0.0001), with asthmatics 
more likely to sleep for less than seven hours per night compared with non-asthmatics (51.3% vs. 
46.6%) 
Figure 1 shows the prevalence of asthma in each sleep duration category. Short sleep 
durations (less than 6 hours) and long durations (more than 8 hours) show an increase in the 
prevalence of asthma compared with 6-8 hours of sleep per night. The lowest prevalence of asthma 
(8.8%) was seen in those who sleep for 7 hours per night on average, while the highest prevalence 
(13.1%) was in those who sleep for 4 hours or less. 
We performed bivariate followed by multivariate logistic regression using SAS 9.4, PROC 
SURVEYLOGISTIC, which takes into account the complex sampling design. We used the 
categorized sleep duration as a main exposure and current asthma as the outcome. Results of the 
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multivariate analysis are presented in Table 2.2.  Both short (6 hours or less) and long (9 hours or 
more) sleep durations were significantly associated with current asthma, compared with 7-8 hours 
of sleep, and the associations remained significant after controlling for potential confounders (OR 
for short sleep duration=1.22, 95% CI 1.06, 1.38, OR for long sleep duration = 1.31, 95% CI 1.06, 
1.62). 
Other variables that were significantly associated with asthma in the study population 
include being overweight, Black race, and female gender. The interaction term for short sleep and 
overweight was statistically significant (coefficient=0.34, P-value= 0.0172). Interaction term for 
long sleep and BMI was not significant.  
Interaction analysis (Table 2.3) shows that, compared with normal weight teens who sleep 
for 7-8 hours per night, those who were overweight and slept for less than 7 hours had 1.75 times 
the odds of having asthma (95% CI 1.45, 2.11), while those who slept for 9 hours or more had OR 
of 2.00 (95% CI 1.32, 3.02).  Relative Excess Risk due to Interaction (RERI) for short sleep and 
overweight was 0.52 (95% CI 0.07, 0.98), and for long sleep and overweight=0.70 (95% CI -0.10, 
1.50), suggesting a  statistically-significant positive additive interaction for short sleep duration 
and overweight, and a positive additive interaction for long sleep duration and overweight, that 
did not reach statistical significance. 
DISCUSSION  
In this large cross-sectional survey of high school students in Florida  (N=16,626), the 
prevalence of asthma was 9.9%, which is very close to the prevalence reported by CDC (2013)41 
for the 15-17 year age group in the US (10.2%, 95% CI  9.1% - 11.3%). Our results demonstrated 
the association between sleep duration that are too short or too long and the increased prevalence 
of current asthma. Effect modification by BMI was observed in the interaction analysis. The 
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associations between short and long sleep durations and asthma were only significant when 
combined with being overweight. Relative Excess Risk due to Interaction (RERI) was statistically 
significant only for the short sleep duration and overweight, while it was non-significant in the 
long duration-overweight group, despite this group having the largest odds ratio. The non-
significant RERI may be due in part to the small sample size in the long sleep duration-overweight 
group (n=229). 
Our findings on the association between short sleep duration and asthma are consistent 
with those found by Jensen at el.35 in children and by Fitzpatrick et al. and Vir et al. in adults.31,32  
Our results on long sleep duration were matched by  Chugh et al., who found that sleep duration 
in asthmatics is significantly longer than it is in non-asthmatics.42 
The combination of asthma, sleep duration, and BMI has been studied previously by 
Teodorescu et al. and by Fedele et al. However, the former examined the combined effect of 
asthma and short sleep duration on obesity,43 while the latter examined the combined effect of 
obesity and asthma on sleep duration.44 Our study sought to complete the triangle by examining 
the combined effect of obesity and short sleep duration on asthma. additionally, we also examined 
the role of long sleep duration, alone and combined with obesity. We have not been able to find 
another study that examined this combination of interactions and associations. 
The National Sleep Foundation recommends that teenagers aged 14-17 sleep for 8-10 hours 
per night, with 7 hours considered appropriate for some teenagers. However, in our study 
population only 25% slept for 8 hours or more and 53% slept for 7 hours or more. We selected our 
cut-off values for short sleep duration based on the lower recommendation, and our long sleep 
cutoff based on the distribution of sleep duration in our sample.  
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Major limitations of this study include the reliance of self-report of all relevant measures. 
Although the asthma question in YRBS has not been validated, the CDC has conducted to 
reliability tests on the national YRBS survey as a whole, and found that three fourths of the 
questions had substantial or higher reliability (kappa > 0.6). Furthermore, a study of adult self-
report of asthma found a substantial agreement (kappa > 0.6) between self-report of asthma 
diagnosis and medical records.45 Moreover, a systematic review by Toren et. al. found that self-
report of asthma diagnosis has a mean sensitivity of 68% (range 48-100) and a mean specificity of 
94% (range 78-100).46 As for self-report of BMI, the CDC has tested the validity and reliability of 
the height and weight questions on the national YRBS, which are identical to the questions on 
Florida YRBS. They  found the self-reported values to be substantially reliable, but compared with 
measured height and weight, students over-reported their height by 2.7 inches on average, and 
underreported their weight by 3.5 pounds on average, which indicates the possibility of an under-
estimation of overweight and obesity in the study population.47 Studies of sleep duration found 
self-report to be valid for large-scale studies of habitual sleep duration, and correspond well to 
objective measures such as actigraphy.48–50  
The second limitation is that the survey included only public school children. Therefore, 
we may not be able to generalize the results to high-school aged youth who are not enrolled in 
schools, or to private school students (around 11%). An additional limitation is our inability to 
control for socioeconomic status, which was not measured in the YRBS. Lastly, the cross-sectional 
nature of this study does not allow for determination of direction of association or for inference 
regarding causality. Nevertheless, it constitutes a stepping stone that will lead further longitudinal 
studies into the path of exploring the complex relationships among sleep duration, BMI, and 
asthma.  
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Our study has many strengths, including the large sample size, the cluster sampling design 
that makes for a representative sample, and the standardized survey instruments. Sleep duration 
was self-reported by the adolescents, which is more accurate than parental reports used in other 
studies.51 Furthermore, the research topic is innovative given that very few studies have examined 
the complex association among sleep duration, obesity, and asthma in adolescents.  
CONCLUSION 
The current study shows that a large proportion of adolescents sleep less than the 
recommended amount for their age. It also suggests that sleep durations that are too short or too 
long are associated with an increased prevalence of asthma in teenagers and that those who are 
overweight are more susceptible to this effect. Sufficient sleep is important for the health and well-
being of teenagers. Moreover, it is known to be associated with increased risk of obesity. Sleep 
interventions may help decrease the risk of persistent asthma in adolescents in addition to 
improving their weight status. Our results indicate that special attention and customized 
interventions must be directed at overweight adolescents, who may benefit for sleep interventions. 
Further studies are needed to validate the results of this study and to establish the direction of the 
above associations.  
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TABLES AND FIGURES 
 
Table 2.1: Select Characteristics of adolescents participating in the Florida Youth Risk 
Behavior Survey (YRBS, 2009 – 2013) 
Variable 
Total sample 
(N=16626) 
With current asthma 
(N=1668, 9.86%) 
Without current 
asthma (N=15060, 
90.14%) 
P-Value 
Age (years) 
<15 
15-16 
>16 
10.2% 
50.1% 
39.7% 
 
10.8% 
49.9% 
39.3% 
 
10.0% 
49.9% 
39.3% 
0.5329 
Sex (% Female) 49.7% 53.1% 49.3% P=0.0020 
Race/Ethnicity: 
White 
Black 
Hispanic 
Other or Multiple 
 
45.8% 
22.8% 
25.8% 
5.6% 
43.6% 
24.8% 
25.6% 
6% 
46.7% 
21.9% 
25.8% 
5.6% 
P=0.0426 
Sleep duration 
<=4 hours 
5 hours 
6 hours 
7 hours 
8 hours 
9 hours 
>=10 hours 
 
9% 
14.1% 
24.1% 
27.7% 
18.5% 
4.5% 
2.1% 
 
12.3% 
16.4% 
22.6% 
24.4% 
17.0% 
5.1% 
2.3% 
 
8.6% 
13.8% 
24.2% 
28.1% 
18.7% 
4.5% 
2.1% 
P<0.0001 
Smoking 13.5% 14.8% 13.3% P=0.0995 
Alcohol 35.9% 38.6% 35.6% P=0.0208 
Marijuana 36.6% 40.3% 36.2% P=0.0002 
Physically active 42.4% 41.7% 42.5% P=0.6086 
BMI (%Overweight) 
 
25.5% 
 
 
30.9% 
 
24.9% P<0.0001 
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Figure 2.1: Prevalence of asthma in each sleep duration category in adolescents participating 
in the Florida Youth Risk Behavior Survey (YRBS) 
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Table 2.2: Results of logistic regression analysis: Association between asthma and selected 
variables in the Florida Youth Risk Behavior Survey (YRBS, 2009-2013) 
 Unadjusted 
OR (95% CI) 
Fully adjusted 
OR (95% CI)* 
Sleep duration categories 
     Short (≤ 6 hours) 
     Good (7-8 hours) 
     Long (>= 9 hours) 
 
1.24 (1.12, 1.38) 
Ref 
1.26 (1.01, 1.57) 
 
1.22 (1.07, 1.40) 
Ref 
1.31 (1.06, 1.63) 
Sex 
     Female  
      Male 
  
1.20 (1.05, 1.35) 
Ref 
Age  
  <15 
  15-17 
   >17  
  
1.16 (0.87, 1.53) 
1.05 (0.89, 1.23) 
Ref 
Race  
  White 
  Black 
  Hispanic 
  Other or multiple  
  
Ref 
1.19 (1.00, 1.40) 
0.84 (0.66, 1.05) 
1.11 (0.94 1.31) 
Smoking  0.98 (0.82, 1.21) 
Alcohol  1.08 (0.95, 1.21) 
marijuana  1.11 (0.98, 1.25) 
Physical Activity  1.01 (0.88, 1.16) 
BMI 
  Normal Weight 
  Overweight 
  
Ref 
1.41 (1.22, 1.62) 
*Bolded odds ratios are statistically significant at the 95% confidence level 
 
Table 2.3: Results of the interaction analysis between sleep duration and BMI and their effect 
on asthma in the Florida Youth Risk Behavior Survey (YRBS, 2009 – 2013) 
 
Normal weight 
Adjusted OR* (95%CI) 
Overweight 
Adjusted OR* (95%CI) 
≤ 6 hours 1.09 (0.94, 1.28) 1.75 (1.45, 2.11) 
7-8 hours 1.00 (REF) 1.14 (0.92, 1.42) 
≥9 hours 1.16 (0.88, 1.53) 2.00 (1.32, 3.02) 
Measure of effect modification on additive scale between short sleep and overweight (95% CI): 
RERI = 0.52 (0.07, 0.98) 
Measure of effect modification on additive scale between long sleep and overweight (95% CI): 
 RERI = 0.70 (-0.10, 1.50) 
*ORs adjusted for age, sex, race-ethnicity, smoking, alcohol, marijuana, physical activity 
  Bolded numbers are statistically significant at the 95% confidence level 
 
 
 
20 
 
 
 
SECTION 3 
 SLEEP DURATION TRAJECTORIES AND ASTHMA 
 FROM ADOLESCENCE TO YOUNG ADULTHOOD 
 
ABSTRACT 
Objectives: This study aims to examine the impact of sleep duration trajectories from 
adolescence into young adulthood on the risk and persistence of asthma into young adulthood. 
Methods: Using data from 12,633 participants in the National Longitudinal Study of Adolescent 
to Adult Health (Add Health), we constructed trajectories of sleep duration for participants 
starting in adolescence (age 13-18) to young adulthood (age 24-32). We constructed separate 
trajectories for participants with asthma and for those without asthma and used them to examine 
the impact of sleep duration patterns on the risk of new-onset asthma, and persistence of asthma 
into young adulthood, respectively, after adjusting for potential confounders. 
Results: Sleep trajectories in non-asthmatic participants showed that 13.8% of them had 
persistent short sleep duration, while 80.7% had adequate sleep durations from adolescence 
though young adulthood. Those with consistently short sleep had 1.59 times the risk of new 
onset asthma by age 32 (95% CI 1.12, 2.26), compared with consistently adequate sleepers. 
Among adolescents with asthma, 10.2% had consistently short sleep through age 24, while 
81.2% had adequate sleep. Short sleepers were 2.35 times more likely than adequate sleepers to 
have their asthma symptoms persist into young adulthood (95% CI 1.12, 4.96).  
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Conclusion: Persistent short sleep duration increases the risk of new-onset asthma in non-
asthmatic adolescents, and the likelihood that those will asthma will continue to suffer from 
asthma symptoms into their young adulthood. 
INTRODUCTION  
The prevalence of asthma has been increasing in recent decades, leading to significant 
morbidity, mortality, and economic impact. In 2009, in the USA alone, asthma was responsible 
for 3,388 deaths; 479,300 hospitalizations; 14.4 million lost school days in children and 14.2 
million lost workdays in adults; and an annual cost of $56.0 million.1 The prevalence of current 
asthma in USA increased between 2001 and 2010 at a rate of 1.5% per year, to a prevalence of 
8.4% in 20103 Despite many studies seeking to identify risk factors and effective interventions, 
the prevalence of asthma is yet to decline. What makes asthma particularly challenging, is its 
multifactorial nature, with many risk factors, including heredity; obesity; and environmental 
exposures, playing a rule in its pathogenesis.52 It is important to identify modifiable risk factors 
that may impact the risk or burden of asthma. Sleep duration is one such factor that deserves 
attention. Growing evidence suggest that lack of sleep, is linked to many deleterious health 
conditions, such as obesity, cardiovascular diseases, and diabetes.11 The most likely mechanisms 
for these associations is through activation of systemic inflammation.8,53,54 Asthma is a chronic 
disease with a underlying inflammatory component, therefore it is possible, at least in theory, 
that chronic sleep deprivation may influence the risk of asthma through the same pathway. 
Asthma is known to cause sleep disruption, leading to reduced quality of sleep,34,55 and 
some cross sectional studies found it to be associated with shorter duration of sleep.33–35 
However, it is unclear whether the association is bidirectional, or whether sleep quantity may 
play a role in the pathogenesis of asthma. The few longitudinal studies that examined the 
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association between sleep and asthma mostly focused on sleep quality rather than duration, 
with some of them finding an association with the risk or morbidity of asthma.13,23,24 The only 
study we found that examined the impact of sleep duration in childhood on the risk of asthma 
in adolescence, with non-significant results, measured sleep duration by parental perception 
that the child sleeps less than other children, rather than the actual duration of sleep.26 More 
recently, a pilot clinical trial by Meltzer et al. found that a two-week experimental sleep 
extension in adolescents with asthma lead to an improvement in their asthma symptoms,  
indicating that sleep duration can affect asthma morbidity and control.56  
This study examines the impact of sleep duration trajectories from adolescence to 
young adulthood on the diagnosis of asthma in adulthood and on the persistence of asthma 
from adolescence into young adulthood. 
METHODS 
Design 
We used data from the National Longitudinal Study of Adolescent to Adult Health (ADD 
Health), which is a nationally representative school-based, longitudinal study that used clustered 
sampling design to enroll and follow participants from adolescence through young adulthood. 
During the first wave of interviews, between April 1995 and December 1995, a total 20,745 
adolescents in in grades 7-12 completed in-home interviews and 17,713 parents completed the 
parent questionnaires. The second follow up period (Waves II,  April 1996 -August 1996) 
included 14,738 adolescent in-home interviews, while the third follow-up period (wave III, July 
2001–April 2002 ) included 15,197 young adult (age 18-24) in-home Interviews. The fourth 
follow-up period (wave IV, January 2008–February 2009) consisted of 15,701 adult (age 24-32) 
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in-home interviews and biomarker collections. More details regarding the design can be found at 
the add health website.57  
This analysis included all subjects enrolled in the study who have answered the questions 
about sleep duration and asthma, and who completed interviews in all four waves. Subjects 
whose parents said they were “mentally retarded” were excluded (n= 196). We also excluded 
participants under 13 years of age as the sleep needs of this age group differ than older 
adolescents. Our final analysis sample included 12,633 participants who had complete data for 
sleep and asthma. 
Measures  
Sleep durations in waves I & II were measured by the respondent’s answer to the 
question “How many hours of sleep do you usually get”. In wave III the respondents were asked 
about the time they go to bed and the time they get up on work/school days and non-work days. 
We calculated the average sleep duration by assigning weights of 5/7 to work nights and 2/7 to 
non-work night.  
Asthma at baseline was measured by the parents’ response to the question “does (your 
child) have asthma?” In wave III respondents were asked “have you ever been diagnosed with 
asthma?”, and in wave IV they were asked “have you ever been diagnosed with: Asthma, 
emphysema, or chronic bronchitis?” Those whose parents answered “no” at baseline and who 
answered “yes” in wave III or in wave IV were considered to have new-onset asthma by wave 
IV. Persistence of asthma was measured by the use of prescription medications for asthma in the 
12 months prior to the wave III interview, in a participant who (1) answered “yes” to the 
question “have you ever been diagnosed with asthma” in wave III, and (2) whose parents 
indicated that he/she had current asthma at wave I. 
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Covariates included in the analysis were age, sex, race, parental income, pubertal 
development, BMI, smoking, alcohol, family history of asthma, and physical activity. 
Race/ethnicity was categorized as Hispanic, Non-Hispanic White, Non-Hispanic Black, 
and other. 
BMI was calculated from self-reported height and weight. We calculated BMI percentiles 
and categorized participants as Underweight: BMI < 5%; Normal weight:   5 ≤ BMI < 85% ; 
Overweight: 85% ≤ BMI < 95% ; and Obese: BMI ≥95%. For adults aged 20 or above, BMI 
categories were Underweight: BMI < 18.5; Normal weight: 18.5 ≤ BMI ≤ 24.9; Overweight: 25 
≤ BMI ≤ 29.9; and Obese: BMI ≥ 30. For the purpose of the analysis, we combined the 
underweight and normal weight into one category called “normal” and combined the overweight 
and obese into one category called “overweight”. 
Family income: After considering family size, we categorized family income as (1) less 
than 150% of the poverty threshold; (2) from 150% to under 250% of the poverty threshold; (3) 
from 250% to under 400% of the poverty threshold; and (4) more than 400% of the poverty 
threshold. 
Parental education was measured as the highest education level of any of the two parents. 
We categorized the education variable as: (1) less than high school; (2) high school degree or 
equivalent; (3) some post-secondary education; (4) college degree; and (5) post-graduate degree. 
Physical activity: We constructed an activity variable as the sum of times per week the 
participant engaged in certain activities (roller-blading, roller-skating, skateboarding, bicycling, 
active sports, and different types of exercise). Participants who received a score of 5-9 were 
considered physically active. We constructed measures of physical activity for each of the four 
waves. 
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A Puberty index was constructed for males and another for female. Each index is the sum 
of scores of each of the five questions the adolescent answered regarding their physical 
development. A median score was calculated for males and females, and each participant was 
categorized as “below the median” and “at or above the median” at baseline. 
Smoking was measured based on the participant’s response to the question “During the 
past 30 days, on how many days did you smoke cigarettes?” Those who smoked on one or more 
days were considered smokers, as per the definition of the National Survey on Drug Use and 
Health (NSDUH)58  
Alcohol was measured by the participant’s response to the question “During the past 12 
months, on how many days did you drink alcohol?” Those who said they drank once a month or 
more were considered drinkers, according to the definition of the NSDUH.59 
Statistical Analysis  
All analyses were performed using SAS 9.4 software. We divided the sample into two 
groups based on asthma diagnosis at wave I, then we identified trajectories of sleep duration 
separately for each group using PROC TRAJ, which uses the semiparametric group-based 
mixture model described by Nagin.60 This model estimates sleep trajectories for each individual 
and classifies individuals with similar sleep duration patterns into different trajectory groups. We 
tried a number of models identifying two to six trajectory groups, and selected the optimal 
number of groups based on the best fitting model for the data that produced the lowest value for 
the Bayesian Information Criterion (BIC), while preserving parsimony. Additionally, we used 
entropy to ensure classification accuracy, for the selected trajectories. Consequently, we 
identified four groups of sleep duration trajectories from waves I to IV for the asthma-free 
sample, and four groups of sleep trajectories from waves I to III for the asthma sample. Each 
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participant was assigned into the group to which he or she had the highest probability of 
belonging.  
We performed descriptive analysis using SAS procedures SURVEYFREQ and 
SUREVEYMEAN that take into account the complex sampling design. Then we used SAS 
GENMOD procedure for the longitudinal regression analysis, for the new-onset asthma in 
asthma-free participants, and for the persistence of asthma in participants with current asthma. 
We started with an unadjusted model for each outcome, and progressed into the multivariate 
model, calculating relative risk and 95% confidence intervals for each outcome.  
RESULTS   
 The study population included 12,633 adolescents, 12.8% of whom had current asthma. 
The asthma group included 1,617 adolescents and the asthma-free group was made up of 11,016 
adolescents. 
 Sleep duration and the risk of new-onset asthma 
Trajectories of sleep duration from wave I-IV in the asthma-free group are shown in 
figure 3.1. The sleep trajectories model with the best fit included four groups: Consistently short, 
consistently adequate, initially short-adequate but increasing, and initially adequate but 
decreasing. Out of all participants, 13.8% had consistently short sleep duration (mean sleep 
duration in the 4 waves ranged from 5.9 – 6.4, median duration 5.4-6.5), while 80.7% had 
consistently adequate sleep duration (mean durations in the four waves ranged from 7.7- 8.0 
hours, median duration 7.3-7.9). Confidence intervals for mean and median durations in these 
two groups did not overlap in any wave. The four trajectory model had an entropy of 0.76, and 
the mean posterior probability for each group ranged from 74% to 89%.  
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There were significant differences among adolescents belonging into different trajectory 
groups in terms of a number of key variables (Table 3.1). Compared with adolescents in the 
consistently adequate group, those in the consistently short group were older, more likely to 
Black, overweight, and to smoke, drink, be physically active, and at a more advanced puberty 
stage (Table 3.1). Those in the initially short but increasing duration group were the youngest, 
most likely to be Black, female, overweight, and have low SES, and a family history of asthma. 
However, they were the least likely to smoke or drink. The long-decreasing duration group had 
the most females (almost the same as the short-increasing group), and had the lowest parental 
education levels. (Table 3.1) 
During the study period, 935 new cases of asthma were diagnosed among participants 
who did not have asthma in wave I (incidence rate=1.04% per year). Table 3.2 shows the results 
of the longitudinal association between sleep trajectory groups and risk of new-onset asthma. 
Compared with the consistently adequate sleep group, the group with consistently short sleep had 
an increased risk for asthma (RR=1.40, 95% CI 1.06, 1.86) which persisted after adjusting for all 
relevant covariates (RR= 1.59, 95% CL 1.12, 2.26). The long-decreasing sleep group showed a 
non-significant increase in risk (adjusted RR=1.53, 95% CI 0.90-2.62), while the short-
increasing sleep group did not show an association with asthma. Other predictors of asthma risk 
included female sex (RR=1.56, 95% CI 1.24, 1.92); family history of asthma (RR=2.02, 95% CI 
1.53, 2.66); smoking (RR=1.25, 95% CI 1.03, 1.53); as well as the “other” racial-ethnic groups.  
Sleep duration and the persistence of asthma into young adulthood 
 We identified four distinct sleep duration trajectories in asthmatic adolescents from wave 
I to III (age 18-24) Figure 3.2.  People in the first trajectory group (10.2% of the sample) had 
consistently short sleep duration (mean duration in waves I – III: 5.6, 5.4, 5.9 hours respectively). 
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The second group included 3.6% of the sample and had initially short sleep duration that increased 
until wave III (mean durations of 6.8, 7.5, and 11.5 hours respectively). The third group included 
the majority of participants (81.2%) and had consistently adequate sleep durations throughout the 
three waves (mean duration 7.9, 7.7, and 7.9 hours respectively), and the fourth group had 4.9% 
of the population with generally long sleep duration throughout (mean durations 10.4, 10.3, and 
8.6 hours respectively). There was no overlap in confidence intervals of mean durations of groups 
at any of the three waves. This model had an average posterior probability for each group that 
ranged from 75% to 89%, and an entropy of 0.75. 
 Young adults who had asthma in wave I and were interviewed in wave III (n=1,395) were 
48.7% female, 68.3% white, and had an average age of 21.8 years at wave III interview (Table 
3.3). The prevalence of overweight in both waves I and III was 24.3%, while 30.9% were 
considered overweight in wave I or III, but not both.  
Logistic regression analysis (Table 3.4) shows that the adolescents with consistently 
short sleep duration had an increased risk of having their asthma persist into young adulthood, 
when compared with adolescents with consistently adequate sleep duration (Adjusted RR=2.35, 
95% 1.12, 4.96). The short-increasing and the long trajectory groups showed a non-significant 
increase in risk of asthma persistence. No other variables in our analysis were significantly 
associated with persistence of asthma.  
DISCUSSION  
This is the first study to examine the impact of changes in sleep duration from 
adolescence into adulthood on the incidence of asthma, as well as its persistence into young 
adulthood. Results of this large longitudinal study indicate that adolescents who are free of 
asthma and consistently sleep for durations through their young adulthood have an increased risk 
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of new-onset asthma by age 32. Likewise, consistently short sleep durations is associated with 
increased likelihood of asthma persistence into young adulthood among adolescent with current 
asthma. 
Sleep trajectories provide a means of more clearly defining sleep patterns in adolescents 
transitioning into young adulthood, compared with the single measurement of sleep duration 
commonly used in cross-sectional and some longitudinal studies. With the use of group-based 
trajectory models, we were able to identify a distinct group of adolescents with persistent short 
sleep duration through young adulthood, which enabled us to study the cumulative effects of 
long-term exposure to short sleep duration on the risk and persistence of asthma. Our sleep 
trajectories from adolescence to young adulthood were not very different from those found by 
Hayley et al.,61 who found 16.5% of adolescents in their data to have sustained short sleep 
duration from ages 15 to 30. Similarly, Gilmour et al.62 found 11.1% of adults (18+) had 
consistently short sleep duration while 87% had short-normal or long-normal sleep trajectories.  
The findings of this research may pave the way for future studies on sleep-related 
interventions that may help reduce the morbidity of asthma as well as the economic burden 
associated with it. Given the recent clinical trial by Meltzer et al.,56 which showed teenagers with 
asthma may benefit from more adequate sleep durations, and the results of our current study, it 
seems likely that interventions targeting sleep duration may help reduce the incidence of asthma 
in non-asthmatic, as well as reduce the long-term morbidity and persistence of asthma symptoms 
in asthmatics. 
It is important to note however, that our data were collected starting in 1994. We 
recognize that current sleep habits of adolescents and young adults may be significantly 
different, especially given the widespread use of smartphones, tablets, and other internet-
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connected devices that may engage users and delay their sleep time, effectively shortening their 
sleep durations. A recent study we conducted using data from the Florida Youth Risk Behavior 
Survey (YRBS), years 2009-2013 showed that nearly 47.2% of adolescents aged 13-19 slept less 
than 7 hours per night, while in the population of the current study, only 16.8% of 13-19 year 
olds slept under 7 hours (in progress). This decline in sleep duration is likely to cause an even 
greater impact on the incidence and persistence of asthma, however, we need to replicate the 
analysis with more recent data to validate the results and verify this impact in our current times 
in order to plan the appropriate interventions. 
Our study has several limitations, starting with the reliance on self-report of sleep 
durations in all four waves. Although some researchers found subjective sleep duration to be in 
poor agreement with objectively measured duration,63 and to over-estimate actigraphy-measured 
sleep duration,64 other studies found self-report to be valid for large-scale studies of habitual 
sleep duration, and corresponds well to objective measures such as actigraphy.48–50  
There were some changes noted in the wording of sleep durations questions at different 
waves. In the first two waves, participants were asked “how many hours of sleep do you usually 
get?” while in the third and fourth waves, they were asked what time they went to sleep and what 
time they got up on nights when they had work or school the next day and on nights when they 
didn’t (weekdays and weekends). We were unable to analyze weekday and weekend sleep 
separately since they were not reported in the first two waves. Therefore, we calculated a 
weighted average for the last two waves in order to obtain a measure that was as consistent as 
possible given the available data. 
There were also some consistencies in measurement of asthma, which was based on 
parental-report in wave I and self-report in waves III & IV. This type of inconsistency is difficult 
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to avoid in longitudinal studies involving adolescents. Moreover, studies show that parental 
reports of the diagnosis and symptoms of asthma agree well with adolescent-reports.51,65  
Another limitation related to asthma measurement was the wording of the questions. In 
wave I, parents were asked whether their child has “asthma or emphysema”, and in wave IV, 
respondents were asked whether they were ever diagnosed with “asthma, chronic bronchitis, or 
emphysema”, which carries the possibility that a fraction of respondents who answer “yes” 
actually have chronic bronchitis or emphysema rather than asthma. It is unlikely for this 
misclassification to cause bias, as most young adults diagnosed with chronic bronchitis actually 
have asthma, or an overlap of asthma and chronic bronchitis.66 Furthermore, emphysema is rare 
in adolescents and young adults, and not known to be associated with sleep duration.67 
Therefore, any possible misclassification is unlikely to be large enough to bias our results. 
Finally, the association between sleep trajectories and the persistence of asthma may have 
been partially explained by severity of asthma in adolescents. It is possible that those with more 
severe asthma had shorter sleep durations that persisted into their adulthood, and were also more 
likely to have their asthma persist into young adulthood. We cannot rule this out given that we 
have no measure of asthma severity at baseline. However, a clinical trial by Meltzer et. Al. 
mentioned above,56 supports our hypothesis that sleep duration may impact asthma symptoms. 
As for the incidence analysis, one might think that the onset of asthma symptoms may have 
affected subsequent sleep trajectories. We do not have a measure of time of onset of asthma to 
rule this out, but it is unlikely that this would have biased our results, given that it is not known 
whether asthma may affect sleep duration, and 34% of new cases were still free of asthma in 
wave III.  
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The major strengths of our study include the longitudinal design and the long follow-up 
period with a response rate of over 77% at each wave. The large representative sample of 
adolescents is another major strength, as is the clustered probability sampling methods. Our use 
of sleep trajectories is an innovative method of studying the impact of sleep duration on the 
incidence of asthma. Furthermore, we created sleep trajectories separately for adolescents with 
asthma and those without asthma, which eliminates the possibility of asthma affecting sleep 
duration trajectories. Finally, the young adult age group that is included is usually under-
represented in epidemiologic studies, and our study may help shed the light on the characteristics 
of this group. 
CONCLUSIONS 
This is the first study to explore the association between sleep trajectories from adolescence 
into adulthood and the risk of adult-onset asthma. The results of this study of a nationally 
representative sample of adolescents indicate that cumulative exposure to short sleep duration can 
increase the risk of developing asthma in non-asthmatics and increase the morbidity of asthma in 
asthmatics. These results raise the question of the long-term impact of persistent sleep loss on the 
risk of asthma later in adulthood. Further studies are needed using more current data that reflect 
the widespread decline in the average sleep duration, and with longer follow-up duration into 
adulthood.  
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TABLES AND FIGURES 
 
 
Figure 3.1: Trajectories of sleep duration from adolescence into young adulthood, in 
participants without asthma at baseline of the Add Health study. 
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Table 3.1: Characteristics of adolescents participating in the Add Health study, who were 
free of asthma in wave I, in total, and by sleep duration trajectory group.  
1 Group 1: Consistently short.                  2Group 2: initially short, increasing. 
 3Group 3: Consistently adequate.        4Group 4: Initially long, decreasing 
*Bolded p-values indicate statistically significant differences among sleep duration groups 
 
 
 
 
 
 
 Variable  
Total 
N=11016   
Group 11  
N=1520 
Group 22 
N=143 
Group 33 
N=8890 
Group 44 
N=463 
P-value* 
Sex (% Female) 50.0% 48% 56.5% 49.9 56.6% 0.3697 
Age (mean ± SD) 15.5±0.2 15.6±0.2 14.7±0.6 15.1±0.2 15.2±0.3 <.0001 
Race (%) 
 White 
 Black 
 Hispanic 
 Other 
 
67.4% 
15.1% 
11.7% 
5.8 % 
 
61.2% 
21.4% 
10.4% 
7.0% 
 
44.2% 
40.0% 
14.0% 
1.8% 
 
68.4% 
13.9% 
11.9% 
5.8% 
 
63.3% 
22.2% 
9.6% 
5.9% 
<.0001 
Overweight or obese (%)        23.3% 29.8% 47.4% 22.5% 21.2% 0.0003 
Family income (%) 
• <150% of poverty threshold 
• 150% - < 250% of threshold 
• 250% - 400%  of threshold 
• >400%  of threshold 
 
27.2% 
22.0% 
28.3% 
22.6% 
 
27.2% 
23.5% 
28.2% 
21.2% 
 
53.5% 
22.3% 
6.9% 
17.2% 
 
26.4% 
21.8% 
28.7% 
23.1% 
 
41.5% 
22.6% 
23.1% 
12.8% 
 
 
0.0032 
Parental education (%) 
• Less than high school 
• High school or equivalent 
• Some post-sec education 
• College degree 
• Post-graduate degree 
 
11.0% 
32.1% 
21.0% 
24.6% 
11.4% 
 
10.2% 
34.3% 
20.2% 
24.9% 
10.5% 
 
17.7% 
34.6% 
36.3% 
9.5% 
1.8% 
 
10.8% 
31.5% 
21.3% 
24.8% 
11.7% 
 
18.0% 
41.4% 
11.5% 
21.7% 
7.3% 
 
 
 
0.0053 
Family history of asthma (%) 10.9% 11.2% 18.2% 10.7% 13.1% 0.0874 
Physically active (%) 24.3% 27.6% 24.5% 24.0% 23.7% 0.5814 
Smoking (%) 25.7% 37.0% 15.3% 24.6% 25.5% <.0001 
Alcohol (%) 15.5% 24.1% 8.4% 14.8% 13.4% <.0001 
Above median puberty level  57.5% 64.4% 40.4% 57.2% 49.8% 0.0082 
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Table 3.2: Results of the regression analysis examining the association between sleep 
duration trajectories from adolescents into young adulthood and the risk of new-onset 
asthma. Analysis of data from the Add Health study 
* Bolded numbers indicate statistically significant associations 
 
 
 
 
 
 
Variable Unadjusted 
RR (95% CI) 
Fully Adjusted Model* 
RR (95% CI) 
Sleep duration trajectory groups 
 Group 1:  Consistently short 
 Group 2:  Increasing 
 Group 3: Consistently normal 
 Group 4: Decreasing  
 
1.40 (1.06, 1.86 ) 
1.32 (0.49, 3.54) 
Ref 
1.35 (0.85, 2.14) 
 
1.59 (1.12, 2.26) 
1.04  (0.30, 3.69) 
Ref 
1.53 (0.90, 2.62) 
Age  0.94  (0.88, 1.00) 
Sex (female)  1.54 (1.24, 1.92) 
Family history  2.02 (1.53, 2.66) 
Race/ethnicity 
 Hispanic 
 Black 
 Other  
 White  
 
 
1.38  (0.99, 1.91) 
1.14  (0.84, 1.50) 
1.55 (1.02, 2.36) 
Ref 
Household income (<250% of poverty 
threshold vs. >= 250% of threshold) 
 0.99 (0.79, 1.26) 
Parental education 
 Less than high school 
 High school or equivalent 
 Some post-secondary education 
 College degree 
 Post-graduate degree 
 
 
0.81 (0.55, 1.18) 
1.03 (0.75, 1.40) 
1.03 (0.73, 1.46) 
1.02 (0.72, 1.44)  
Ref 
Smoking   1.25 (1.03, 1.53) 
Alcohol  0.86 (0.64, 1.16) 
Physically active   0.99 (0.76, 1.29) 
Pubertal category  1.16 (0.95, 1.21) 
Overweight   1.09 (0.83, 1.44) 
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Figure 3.2: Trajectories of sleep duration from waves I to III of the Add Health study, 
among participants with asthma in wave I 
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Table 3.3 Characteristics of participants in wave III of the 
 ADD health study who had asthma in wave I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Variable  % of Total (N=1,395) 
Sex (% Female) 48.7% 
Age at wave III (mean , 95% CI) 21.8 (21.5-22.0) 
Race (%) 
 White 
 Black 
 Hispanic 
 Other 
 
68.3% 
15.9% 
5.4% 
68.3% 
 Overweight in both waves 
 Overweight in wave I or III 
 Normal weight in both waves 
24.3% 
30.9% 
44.8% 
Family income (%) 
• <150% of poverty threshold 
• 150% - < 250% of threshold 
• 250% - 400%  of threshold 
• >400%  of threshold 
 
26.5% 
24.8% 
25.1% 
23.6% 
Parental education (%) 
• Less than high school 
• High school or equivalent 
• Some post-secondary education 
• College degree 
• Post-graduate degree 
 
8.9% 
31.6% 
25.3% 
22.4% 
11.8% 
Family history of asthma (%) 35.9% 
Physically active at wave III (%) 21.2% 
Smoking at wave III (%) 36.4% 
Alcohol at wave III (%) 11.2% 
Above median puberty level at w I 62.4% 
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Table 3.4: Association between short sleep durations trajectories and persistence of asthma 
into wave III in participants who had asthma at wave I of the add health study.  
 
 
 
Variable Unadjusted 
OR (95% CI) 
Fully adjusted model* 
OR (95% CI) 
Sleep duration trajectory groups 
 Group 1:  Consistently short 
 Group 2:  Increasing 
 Group 3: Consistently normal 
 Group 4: Long 
 
1.66 (0.90, 3.10) 
1.06 (0.43, 2.71) 
Ref 
0.92 (0.41, 2.11) 
 
2.35 (1.12, 4.96) 
1.22 (0.47, 4.02) 
Ref 
1.10 (0.48, 2.78) 
Age  0.98 (0.86, 1.13) 
Sex (female)  1.43 (0.97, 2.10) 
Race  
 Hispanic 
 Black 
 Other  
 White  
 
 
0.91 (0.62, 1.62) 
1.20 (0.70, 2.02) 
1.15 (0.68, 2.22) 
Ref 
household income (<250% of poverty 
threshold vs. >= 250% of threshold)  1.39 (0.90, 2.17) 
Parental education 
 Less than high school 
 High school or equivalent 
 Some post-secondary education 
 College degree 
 Post-graduate degree 
 
 
0.69 (0.29, 1.76) 
0.89 (0.56, 1.60) 
1.15 (0.68, 1.85) 
1.05 (0.57, 1.87) 
Ref 
Pubertal status w1 (less than median vs. 
median or above) 
 1.24 (0.84, 1.82) 
Smoking   0.78 (0.52, 1.19) 
Alcohol   1.10 (0.48, 1.73) 
Overweight in both waves 
Overweight in wave I or III 
Normal weight in both waves 
 
1.24 (0.80, 1.90) 
1.32 (0.86, 2.05) 
Ref 
Physically active  0.96 (0.66, 1.40) 
* Bolded numbers indicate statistically significant findings 
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SECTION 4 
SLEEP DURATION TRAJECTORIES AND SYSTEMIC INFLAMMATION IN 
YOUNG ADULTS: RESULTS FROM THE NATIONAL LONGITUDINAL STUDY OF 
ADOLESCENT TO ADULT HEALTH (ADD HEALTH) 
 
ABSTRACT 
This study examines the effects of consistently short and consistently long sleep durations 
in young adults on the levels of CRP, as well as the potential effect modification by sex. Using 
data from waves III (age 18-26) and IV (age 24-32) of the National Longitudinal study of 
adolescent to adult health, we examined the association between sleep trajectories in young 
adults, and the risk of elevated high sensitivity C-reactive protein (hs-CRP), a marker of systemic 
inflammation. Short sleep trajectories were associated with a significant increase in log-
transformed hs-CRP (coefficient=0.11, p-value 0.03), and with a significant increase in the odds 
of having hs-CRP levels >3 mg/dl (OR=1.86, 95% CI 1.29, 2.67). The association was modified 
by sex, with the association between short sleep duration and hs-CRP limited to males. Both the 
continuous (coefficient 0.117, p-value=0.0362) and the categorized hs-CRP (OR= 2.21, 95% CI 
1.48, 3.30) were significantly increased with short sleep durations in males, while no significant 
associations were seen in females with short sleep durations. By contrast, there was a significant 
increase in log hs-CRP in females with long sleep durations (coefficient=0.232, p-value=0.0296), 
and a non-significant increase in the odds of having hs-CRP levels greater than 3 mg/dl 
(OR=1.48, 95% CI 0.75, 2.93), while there were no associations with long sleep duration in 
males.  
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INTRODUCTION 
Sleep loss is an increasingly prevalent public health problem with more than 35% of US 
adults sleeping less than the recommended 7 hours per night.68 Sleep durations that are very short 
or very long have been implicated in the risks of obesity, cardiovascular diseases, and 
depression, among other conditions.8 Recent studies pointed to the production of pro-
inflammatory cytokines, including C-reactive protein (CRP), an acute phase reactant, as a 
possible pathway that explains these associations.8 While experimental sleep deprivation studies 
found an association between acute sleep loss and CRP levels, population-based studies had 
inconsistent results, with some  finding a significant association between short,69–71  or long 72–75 
sleep durations and CRP, while others found no significant associations.76–78. Some studies found 
the association to be limited to women,25,11,79 or men.80 The majority of these studies were cross-
sectional. In order to confirm whether systemic inflammation is indeed the mediating factor in 
the association between sleep duration and negative health outcomes, it is imperative to 
determine first whether sleep duration is associated with systemic inflammation, using large 
population-based longitudinal studies. These studies are lacking, especially in young adults, and 
none- to our knowledge- has used trajectories of sleep duration to examine the association 
between sleep and inflammation in young adults. 
This study examines the effects of consistently short and consistently long sleep durations 
in young adults on the levels of CRP, as well as the potential effect modification by sex. 
METHODS 
Design 
This study uses data from waves  III and IV of the National Longitudinal Study of 
Adolescent to Adult Health (Add health), which is a nationally representative study of adolescent 
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health and behavior in the USA that used clustered sampling design to select adolescents in 
grades 7-12, and followed them through 4 waves of interviews into early adulthood (age 24-32). 
Of the 17,670 participants who had completed in-home and parental interviews at wave I (1994–
1995), 15,197 completed interviews in wave III and 15,701 were interviewed in Wave IV, with a 
response rate of 80% in wave IV. This analysis includes participants who were seen at waves III 
and IV and have a valid measurement of CRP (N=10,744).  
Measures 
High-sensitivity CRP (hs-CRP) was collected during wave IV interview using capillary 
blood spots that were dried, frozen, and assayed using an adapted DBS (Dried Blood Spot) 
sandwich ELISA procedure cross-validated with paired plasma samples (r = 0.98; N = 80 
matched serum samples). More details are available online (see “Add Health IV Documentation: 
Measures of Inflammation and Immune Function”).81 
Because the distribution of hs-CRP was right-skewed, we used natural log-transformation 
prior to the analysis. We analyzed log-transformed hs-CRP as a continuous variable, and hs-CRP 
as a categorical variable, using values ≤3 mg/L (low-to-average risk) as the reference value, and 
>3 mg/L as the main outcome value. For the main analysis, we excluded values of hs-CRP > 10 
mg/dl, as they are known to be associated with acute infectious or inflammatory conditions, and 
were present in 12.4% of the study sample. We later performed sensitivity analysis including 
values of hs-CRP > 10 mg/dl to check their impact on the results.  
Sleep duration was measured in waves III & IV by the participant’s answers to questions 
about bed-time and wake-up times on work/school nights and non-work nights. We calculated a 
weighted average sleep duration for each participant at each wave by assigning weights of 5/7 to 
work nights and 2/7 to non-work night. 
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Body Mass Index (BMI) calculated from measured height and weight in waves III & IV. 
A participant was considered overweight if he/she had a BMI > 25.0 kg/m2. In order to capture 
effects of long-standing overweight, we constructed a variable that combined waves III & IV 
BMIs into one variable with 3 categories: (0) if normal weight in both waves, (1) if overweight 
in one of the two waves, (2) if overweight in both waves. 
Demographic variables included age, sex, & race-ethnicity  
Measures of socioeconomic status in wave IV included  
 Total household income in wave IV before taxes and deductions. We categorized the 
income variable as follows: (1) less than $50,000 per year, (2) $50,000 – $99,999 per 
year, and (3) more than $100,000 per year. 
  Educational level: Participants were asked about their highest level of education, 
with choices ranging from (1) 8th grade or less, to (13) completed post baccalaureate 
professional education. We categorized the education variable into (1) less than high 
school graduate, (2) high school graduate to some post-secondary education, and (3) 
college degree or more. 
Behavioral factors  included:  
 Smoking: Participants were asked, “During the past 30 days, on how many days did you 
smoke cigarettes?” Those who smoked on one or more days were considered current 
smokers, as per the definition from the National Survey on Drug Use and Health 
(NSDUH)58  
 Alcohol: Participants were asked, “During the past 12 months, on how many days did 
you drink alcohol?” Those who said they drank once a month or more were considered 
drinkers, according to the definition of the NSDUH. 
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 Physical activity measure was constructed from a series of seven questions about the 
frequency of engaging in certain physical activities. The binary measure included in the 
data set was coded as 0=bouts of physical activity, 1=no bouts of physical activity.  
Illnesses and Medications: Hs-CRP is sensitive to many illnesses and medications; therefore, 
we adjusted for these conditions in the analysis using the following variables: 
 Subclinical symptoms: A count of the number of symptoms the participants reported, 
including cold or flu symptoms, fever, night sweats, nausea, vomiting, or diarrhea, blood 
in stool or urine, frequent urination, and skin rash or abscess in the past two weeks. 
Counts range from 0 to ≥3 
 Infectious or inflammatory diseases: A count of lifetime diagnoses of conditions including 
asthma / chronic bronchitis / emphysema, lifetime diagnosis of hepatitis C, in addition to 
gum disease, active infection, injury, acute illness, surgery, and active seasonal allergies in 
the past 4 weeks. Counts range from 0 to ≥3 
 Other illnesses or conditions: Hypertension, depression, and snoring (indicative of 
obstructive sleep apnea) 
 Medications that may affect hs-CRP: NSAID/Salicylate, Cox-2 inhibitors, inhaled 
corticosteroids, corticotropin/glucocorticoids, antirheumatic/antipsoriatic,  
immunosuppressive, and anti-inflammatory medictions 
Data analysis  
We identified trajectories of sleep duration using PROC TRAJ in SAS 9.4®, which uses 
the semiparametric group-based mixed model described by Nagin.60 This model estimates sleep 
trajectories for each individual and classifies individuals with similar sleep duration patterns into 
trajectory groups. We tried a number of models identifying two to five trajectory groups. 
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Selection of the optimal number of groups was based on the best fitting model for the data that 
produced the lowest value for the adjusted Bayesian Information Criterion (BIC),82  while 
preserving parsimony and facilitating interpretability. Additionally, we used entropy as a 
measure of classification accuracy.82 Consequently, we identified three groups of sleep duration 
trajectories from waves III to IV. Each participant was assigned into the group into which he or 
she had the highest probability of belonging.  
Descriptive analyses included calculation of means and confidence intervals for 
continuous variables and frequencies of categorical variables. It was performed using SAS 9.4 
procedures SURVEYMEANS and SURVEYFREQ, which take into account the complex 
sampling design. 
Using SURVEYREG procedure in SAS, we ran regression analysis models examining 
the association between sleep duration trajectories and the natural logarithm of hs-CRP, first 
unadjusted, then after adjusting for covariates, obtaining coefficients and p-values. We examined 
interaction with sex by adding an interaction term to the model, and obtaining coefficients and p-
values. We then performed the same analysis stratified by sex. 
We examined the association with hs-CRP categories using SAS procedure 
SURVEYLOGISTIC, starting with an unadjusted model, then adding covariates to obtain 
adjusted odds ratios and 95% confidence intervals. We examined interactions between sleep 
duration and sex by adding an interaction term to the model. Then we performed the same 
analysis above, stratified by sex. 
RESULTS  
Figure 1 shows the sleep duration trajectories from wave III to wave IV by average age 
at each wave. The three distinct trajectories represent participant with short sleep durations in 
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both waves (group 1), those with good duration in both waves (group 2), and those with long 
duration in both waves (group 3). Our model had an entropy of 0.75, and the mean posterior 
probability for belonging into each of three groups was between 73% and 91%, with a minimum 
above 50%. Group 1 participants had median sleep durations in waves III & IV of 5.5 and 5.8 
hours, respectively. Group 2 had median durations of 7.9 & 7.8 hours, and group 3 had median 
durations of 10.7 & 10.6 hours in waves III & IV respectively (Table B.1). 
Characteristics of the study population are presented in Table 1. The analytic sample 
consisted of 10,744 participants, 50.4% of whom were females, 66.4% white, and the mean age 
at wave IV was 28.4 years. Short sleep duration trajectory included 10.6% and long sleep was 
present in 2.7%. There were significant differences among people belonging into different 
trajectory groups in terms of several key variables. Compared with good sleepers, those with 
short sleep trajectories were significantly more likely to have hs-CRP>3 mg/dl (40.9% vs. 
31.4%). They were also more likely to be Male (69.3% vs. 49.7%), Black (23.6% vs. 14.5%), 
overweight in both waves (52.6% vs. 46.5%), of lower education and income, and to smoke, 
have hypertension, depression, or snoring. Long sleepers were the most likely to be female 
(64.5%), Black (41.2%), have income below $50.000 ,  high school degree or less, and to have 
no bouts physical activity. However, they were the least likely to smoke, drink, snore, or have 
trouble sleeping (Table 1). Both the short and the long sleep duration groups had higher mean 
Log-transformed hs-CRP (1.13, 1.21 respectively) compared with the good sleep duration group 
(1.05), however the differences were not statistically significant. (Table 1) 
Regression analysis results (Table 2) show that hs-CRP increases significantly with 
consistently short sleep duration compared with good sleep durations, after adjusting for relevant 
covariates (coefficient=0.111, p-value=0.0327). Long duration trajectories were also significant 
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in the unadjusted model (coefficient= 0.154, P-values=0.0244), and in the fully adjusted model 
(coefficient=0.200, P-value=0.0145). Other significant variables included female sex (P <.0001), 
overweight in one or both waves (P<.0001), low educational level, lack of physical activity, 
hypertension, and snoring. There was a borderline significant interaction between female sex and 
short sleep duration (P=0.0494), and a significant interaction between long sleep duration and 
being overweight in both waves (P=0.0130) 
Logistic regression examining categorical hs-CRP as an outcome (Table 3) shows that, 
similar to linear regression on Ln hs-CRP, short sleep duration raised the odds of having hs-
CRP>3 mg/dl  in the unadjusted model, and the effect persisted and became more pronounced 
after adjusting for relevant covariates (OR=1.86, 95% CI 1.29, 2.67). Long sleep duration was 
not significantly associated with categorical hs-CRP in any of the models.  
Other variables that were significantly associated with hs-CRP>3 mg/dl included female 
sex (adjusted OR=2.44, 95% CI 2.09-2.85), overweight in one wave OR=3.36 (2.82, 4.02), and 
overweight in both waves OR=1.97 (1.62, 2.39), in addition to low education level (high school 
degree, compared with college degree or more), hypertension, snoring, and lack of physical 
activity. Medications and symptoms of infection were not significantly associated with increased 
CRP, but subclinical symptoms of inflammatory diseases did produce a statistically significant 
OR with 1, 2, and 3 or more symptoms. Race,  smoking, drinking, and trouble sleeping were not 
significantly associated with CRP in the adjusted model. 
Interaction term sex*sleep duration groups was significant for short sleep and female sex, 
compared with good sleep and male sex (P= 0.0380). Stratified analysis by sex (Table 4) 
revealed that the association between short sleep duration and hs-CRP is limited to males. Both 
the continuous and the categorical hs-CRP were significantly increased in males who had short 
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sleep durations, while no association was found in females. By contrast, there was a significant 
increase in log hs-CRP in females with long sleep durations, and a non-significant increase in the 
odds of having hs-CRP levels greater than 3 mg/dl, while there were no associations in males.  
Sensitivity analysis: Results of multivariate regression including hs-CRP values greater 
than 10 were not very different. In logistic regression (Table B.2), short sleep trajectory group 
produced an adjusted OR of 1.74 (1.26, 2.39), which is slightly lower than the one we had while 
excluding extremely high hs-CRP values. Similar to the original analysis, long sleep trajectories 
were not significantly associated with hs-CRP > 3mg/dl. Furthermore, in the linear regression, 
short sleep trajectories were associated with had an adjusted coefficient of 0.10 and P-
value=0.0492. Long sleep trajectories were not significant in the adjusted model (Table B.1). 
DISCUSSION  
This prospective analysis of a nationally representative sample of US young adults 
revealed different relationships between sleep duration and hs-CRP levels among men and 
women, Men who consistently sleepless than the recommended seven hours per night have a 
significant increase in systemic inflammation, measured by hs-CRP, while no association is 
detected in females. By contrast, women appear to be more sensitive to long sleep durations, 
which are associated with an increase in hs-CRP in young women but not young men. 
Long sleep duration was significantly associated with the increase in hs-CRP in women, 
which is consistent with previous studies,75,83,84 but it was not statically significant when hs-CRP 
was used as a categorized variable. This may be due to lack of power due to the small number of 
participants in the long trajectory group (n=106 females), or may reflect an association with the 
increase in hs-CRP, rather than with the probability of having hs-CRP >3 mg/dl, compared with 
values ≤3 mg/dl. Further studies using hs-CRP categories are needed to clarify.  
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Our results are somewhat consistent with those found by Ferrie et al.,70 in their 
longitudinal analysis from the Whitehall II study of middle-aged men and women, using two 
measures of sleep duration 5 years apart. They found the decrease in sleep duration to be 
significantly associated with the increase in hs-CRP, but the association was no longer 
significant after adjusting for BMI, hypertension, and diabetes. Unlike Ferrie et al., we adjusted 
for medication use, symptoms of infectious and inflammatory diseases, and sleep problems. 
Similarly, the Coronary Artery Risk Development in Young Adults (CARDIA) study78 found a 
significant association between sleep duration at baseline and CRP levels 5 years later, but 
similar to Ferrie et al.’s study above, the association was attenuated to non-significant after 
adjusting for covariates. This study used CRP as a continuous variable and unlike our analysis, 
had only one measurement of sleep duration at baseline, categorized as short (<6 hours) or usual 
(6 h or more). Both of the studies above had older cohorts than ours, and smaller sample sizes 
(5003, 2679, respectively), that may explain the non-significant results. Neither of the two 
studies examined the interaction between sleep duration and sex. 
Our finding of significant effect modification by sex requires further study. We found 
short sleep in men and long sleep in women to be associated with increased hs-CRP. In contrast, 
Miller et. al.’s analysis from the Whitehall II study 77 found the association between short sleep 
duration and hs-CRP to be limited to females. Furthermore, they found an increase in hs-CRP in 
women who slept for more than 8 hours, but unlike our results, it was not statistically significant. 
Miller et. al.’s analysis was cross-sectional, with an older cohort and a smaller sample size (n = 
4677) than ours, which may explain the non-significant results. Our findings of an association 
between long sleep duration and log-transformed hs-CRP that is limited to women is consistent 
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with  the Nurses’ Health Study75, that included 935 women aged 43-69 years, and found an 
association between long sleep duration and hs-CRP (as a continuous variable) in women.  
In a recent study using data from Add health, Mantua & Spencer 85 examined the 
interactive effects of nocturnal sleep and daytime naps in relation to hs-CRP. This study included 
2147 participants, and measured sleep duration in wave III only. They found that short sleepers 
had the highest hs-CRP, but did not find a significant effect of sleep duration on hs-CRP in their 
regression model. The smaller sample size may be responsible for the lack of significant results. 
This is the first study to our knowledge that used sleep trajectories to examine the 
association between sleep duration and CRP. Our sleep trajectories matched those found by 
Gilmour et. al.62 in a study of Canadians during the same time period as our study. Their short 
duration trajectory included 11.1% of the population, and the long duration trajectory included 
2.1%. In comparison, our short and long trajectories included 10.6% and 2.7% of our population 
respectively. 
The main limitation of this analysis was the reliance on self-reported sleep durations in 
waves III & IV, which raises the question of agreement between subjectively and objectively 
measured sleep duration. Self-report was found by Lauderdale et. al. to over-estimate actigraphy-
measured sleep duration.64  By contrast, several studies found self-report to be valid for large-
scale studies of habitual sleep duration, and correspond well to objective measures such as 
actigraphy.48–50  
Another limitation is the lack of measurement of CRP prior to wave IV, which does not 
allow for determination of temporality. As with many chronic health outcomes that produce no 
symptoms, it is very difficult to capture the onset of systemic inflammation. We are cautious in 
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interpreting the results of our analysis, and realize the need for further longitudinal studies with 
multiple measurements of CRP.  
Major strengths of this study include the large cohort of US young adults, an under-
represented group in epidemiologic research, and the complex sampling design that insures the 
sample is representative of US population. Additional strengths include the longitudinal design, 
and utilization of group-based trajectory modeling to predict the impact of sleep duration 
patterns on levels of hs-CRP.  
CONCLUSION 
Accumulating evidence point to sleep loss, as well as excess sleep as modifiable risk 
factors for many acute and chronic diseases, resulting in significant public health burden. It is 
therefore very important to understand the mechanism of these associations. The present study 
supports previous research indicating a link between sleep duration and inflammation, which 
partially explains the detrimental effects of inadequate sleep. It also indicates that the impact of 
inadequate sleep duration differs between males and females, which will help guide public health 
interventions and sleep education efforts. More prospective studies are needed to understand the 
mediating effect of inflammation on the risk 
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Tables and Figures 
 
 
Figure 4.1: Trajectories of sleep duration between waves 3 and 4 of the Add Health study  
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Table 4.1: Selected characteristics of participants in waves 3 & 4 of the National Longitudinal 
Study of Adolescent to Adult Health, in total and stratified by sleep duration trajectory 
group  
 
 
 
 
 Variable  Total 
(N=10741) 
Short  
(10.6%) 
Good  
(86.7%) 
long 
(2.7%) 
P-value 
Age in wave 4 (mean)  
             ( 95% CI) 
28.4  
(28.2 -28.6) 
28.6 
(28.3 - 29.0) 
28.4 
(28.2 - 28.6) 
28.6 
(28.1 – 29.1) 
0.1790 
Log-transformed CRP (mean) 
        (95% CI)      
1.06 
(1.04 - 1.08) 
1.13 
(1.04 - 1.22) 
1.05 
(1.03 - 1.07) 
1.21 
(1.07 – 1.34) 
0.5637 
CRP > 3 mg/dl (%) 32.0% 40.9% 31.4% 35.9% 0.0055 
Sex (% female) 50.4% 30.7% 51.3% 64.5% <.0001 
Race/ethnicity (%) 
 White 
 Black 
 Hispanic 
 Other 
 
66.4% 
15.3% 
11.8% 
6.4% 
 
57.7% 
23.6% 
11.4% 
7.3% 
 
67.2% 
14.5% 
11.8% 
6.5% 
 
46.1% 
41.2% 
10.9% 
1.8% 
 
 
<.0001 
Overweight 
-  In one wave (%)        
-In both waves (%)  
 
24.7% 
46.8% 
 
25.8% 
52.6% 
 
24.5% 
46.5% 
 
38.9% 
47.2% 
 
     0.0390 
Household income (%) 
 < $50.000 
 $ 50.000 - $100.000 
 > $100.000 
 
49.5% 
36.8% 
13.7% 
 
52.6% 
36.3% 
11.1% 
 
48.9% 
37.0% 
14.1% 
 
72.4% 
23.9% 
3.8% 
 
 
0.0002 
Educational level 
 Less than high school 
 High school diploma 
 Some post-secondary education 
 College degree or higher 
 
8.5% 
17.3% 
43.8% 
30.4% 
 
10.9% 
19.8% 
49.0% 
20.2% 
 
8.3% 
16.8% 
43.5% 
31.5% 
 
10.7% 
44.4% 
41.6% 
3.3% 
 
 
 
<.0001 
No Physical activity (%) 15.0% 12.7% 14.8% 30.4% <.0001 
Smoking (%) 31.0% 43.7% 30.4% 25.8% <.0001 
Alcohol (%) 58.9% 58.5% 59.1% 39.7% 0.0246 
Hypertension 25.3% 32.3% 24.8% 31.6% 0.0084 
snoring 49.7% 60.5% 49.2% 42.4% <.0001 
depression 20.7% 24.2% 20.4% 23.3% 0.2662 
Trouble sleeping or staying asleep 
(1 or more per week) 
67.8% 64.3% 68.3% 50.6% 0.0016 
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Table 4.2: Results of multivariate linear regression analysis for natural logarithm of CRP 
and sleep duration in waves 3 & 4 in the Add Health study (Regression coefficients and P-
values) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
§ Fully adjusted model also included symptoms of infection, subclinical symptoms of inflammatory disease, 
& medication use (not shown in table) 
 
 
 
 
 UNADJUSTED 
COEFFICIENT (P-
VALUE) 
FULLY ADJUSTED§ 
Sleep duration  trajectory group 
 Short 
 Good 
 Long 
 
0.08 (0.0875) 
Ref 
0.15 (0.0244) 
 
0.10 (0.0327) 
Ref 
0.20 (0.0145) 
Sex (female)  0.27 (<.0001) 
Race/ethnicity 
 Black 
 Hispanic 
 Other 
 White 
  
-0.02  (0.3580) 
-0.0001 (0.9862) 
- 0.06  (0.1051) 
Ref 
 Overweight in both waves 
 Overweight in one wave 
 Normal weight in both waves 
 0.42 (<.0001) 
0.25 (<.0001) 
Ref 
Education 
 Less than high school 
 High school diploma 
 Some post-secondary education 
 College degree or higher 
  
0.09 (0.0291) 
0.12 (<.0001) 
0.08 (0.0005) 
Ref 
Income   
     < $50.000 
     $ 50.000 - $100.000 
 > $100.000 
  
0.02 (0.4805) 
0.004 (0.8563) 
Ref 
Alcohol use  -0.08 (0.0519) 
Smoking  0.01 (0.7227) 
Lack of physical activity  0.06 (0.0150) 
Hypertension  0.10 (0.0001) 
Depression  0.01 (0.5726) 
Snoring  0.08 (<.0001) 
Trouble sleeping  0.01 (0.2614) 
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Table 4.3: Association between sleep in waves 3 & 4 and CRP levels greater than 3 mg/dl in 
the Add Health study (Odds ratios and 95% C.I.) 
 Unadjusted Fully adjusted 
Sleep duration trajectory group 
 Short 
 Good 
 Long 
 
1.51 (1.12, 2.04) 
Ref 
1.22 (0.82, 1.84) 
 
1.86 (1.29, 2.67) 
Ref 
1.25 (0.67, 2.35) 
Sex (female)  2.44 (2.09, 2.85) 
Race/ethnicity 
 Black 
 Hispanic 
 Other 
 White 
  
0.95 (0.74, 1.22) 
0.98 (0.80, 1.21) 
0.78  (0.57, 1.06) 
Ref 
 Overweight in both waves 
 Overweight in one wave 
 Normal weight in both waves 
 3.36 (2.82, 4.02) 
1.97 (1.62, 2.39) 
Ref 
Education 
 Less than high school 
 High school diploma 
 Some post-secondary education 
 College degree or higher 
  
1.13 (0.85, 1.52) 
1.30 (1.03, 1.66) 
1.13 (0.95, 1.36) 
Ref 
Income   
 < $50.000 
  $ 50.000 - $100.000 
 > $100.000 
  
1.14 (0.91, 1.43) 
1.05 (0.85, 1.29) 
Ref 
Alcohol use  0.86 (0.74, 1.01) 
Smoking  1.03 (0.88, 1.20) 
Lack of physical activity  1.32 (1.08, 1.61) 
Hypertension  1.40 (1.17, 1.68) 
Depression  1.05 (0.85, 1.29) 
Snoring  1.30 (1.13, 1.49) 
Trouble sleeping  1.01 (0.98, 1.04) 
§ Fully adjusted model also included symptoms of infection, subclinical symptoms of inflammatory 
disease, & medication use (not shown in table) 
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Table 4.4: Results of sex-stratified regression analysis examining the association of sleep trajectory 
groups and continuous log hs-CRP as well as categorical CRP in the Add health study: 
  
 Sleep duration trajectory groups 
 Short Good Long 
Males    
CRP >3 mg/dl  (OR, 95% CI) 
vs. ≤ 3 mg/dl 
2.21 (1.48, 3.30) Ref 0.94 (0.21, 4.11) 
 Ln hs-CRP (coefficient, p-value) 0.117 (0.0362) Ref 0.176 (0.1813) 
Females    
CRP >3 mg/dl  (OR, 95% CI) 
vs. p ≤ 3 mg/dl 
0.998 (0.54, 1.86) Ref 1.52 (0.77, 2.95) 
Ln hs-CRP (coefficient, p-value) -0.004 (0.9544) Ref 0.232 (0.0296) 
Results shown are of the fully adjusted models, which included Race, BMI, education, income, smoking, 
alcohol, physical activity, depression, hypertension, trouble sleeping, symptoms of infection, subclinical 
symptoms of inflammatory disease, & medication use. 
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SECTION 5 
CONCLUSIONS AND RECOMMENDATIONS 
 
 The results of this dissertation research point to the detrimental effects of sleep loss on the 
bodies of adolescents and young adults. Sleep duration has previously been linked with a range of 
conditions, from obesity to cardiovascular disease, metabolic syndrome, and other negative health 
outcomes. In our research, we found sleep loss to be associated with the incidence of asthma and 
its persistence, in addition to heightened systemic inflammation, which is a likely pathway that 
links sleep duration with the above outcomes. 
In our first study, using the Florida YRBS, we examined the cross-sectional association 
between sleep duration and the prevalence of current asthma in adolescents. We found that 
adolescents with short or long sleep duration were more likely to have current asthma than those 
with adequate sleep durations. Overweight adolescents were more susceptible to the effects of 
short sleep duration on asthma. 
The second study, using data from Add health examined the association between 
longitudinal trajectories of sleep duration from adolescence to young adulthood and the risk and 
persistence of asthma. Our results indicated that non-asthmatic adolescents who sleep for short 
durations consistently through their young adulthood are at a higher risk of developing asthma by 
age 32. Adolescents with asthma who consistently sleep for short durations are at a higher risk of 
having their asthma symptoms persist into young adulthood (age 18-24).  
In our third study, using Add health data, we found that young adults who consistently 
sleep for short durations are more likely to have increased levels of C - reactive protein (CRP), a 
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marker of systemic inflammation. The association was mostly limited to males, while females 
had a more significant association between long sleep duration and CRP. 
We used innovative measures of sleep duration in our longitudinal studies. Using 
trajectories of sleep durations from adolescence into young adulthood, we classified participants 
according to their patterns of sleep. In all the models we used, there was always a group of 
participants who consistently slept less than the recommended amount for their age.  Another 
group, usually the largest, consistently slept for an adequate amount through the follow-up 
period of Add health study. The use of trajectories enabled us to examine the impact of 
consistently short sleep duration from adolescence through young adulthood, which is 
informative than a single measure of self-reported sleep commonly used in cross-sectional and 
many longitudinal studies.  
Our cross-sectional analysis was the first step that revealed the association between sleep 
duration and asthma, and it acted as a stepping stone towards the more extensive longitudinal 
analysis. The cross-sectional analysis used more recent data (2009-2013), while the adolescent 
stage of the longitudinal date were collected between 1994-1996. The time difference helped 
shed the light on the change in average sleep duration in adolescents over the past 20 year. The 
proportion of adolescents sleeping less 7 hours per night changed dramatically between the two 
studies. In the Add health study, 16.5% of adolescents slept less than 7 hours in 1994-1995, 
while 47.2% of participants in Florida YRBS (2009-2013) slept less than 7 hours. This decrease 
in sleep duration, likely to be caused by the widespread use of mobile phones and other internet-
connected devices, highlights the need to determine the effects of sleep loss on the growing 
bodies of adolescents, and to design effective interventions that address this public health 
problem. 
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Although our third study could not answer the question whether the association between 
sleep duration and asthma was mediated by systemic inflammation, it solved a piece of the 
puzzle, and paved the way to further studies that will answer this question. Before we can 
determine whether the association is indeed through the inflammatory pathway, we need to 
confirm the longitudinal association between consistently short sleep duration and systemic 
inflammation. The effect-modification by sex is an important, yet unexpected findings that needs 
further examination.  
 This research was limited by the use of self-reported sleep duration and asthma 
diagnoses, and the lack of a measure of asthma severity. Given the cost associated with objective 
measures of sleep duration, it is not feasible to use them in large population-based longitudinal 
studies. Nevertheless, several studies found self-report to be valid for large-scale studies of 
habitual sleep duration, and correspond well to objective measures such as actigraphy.48–50 The 
lack of measure of asthma severity is a cause for concern, particularly in the study of asthma 
persistence, as it is possible, in theory, that adolescents with more severe asthma had shorter 
sleep durations, and were also more likely to have their asthma symptoms persist into young 
adulthood. We are planning future studies that will verify the results of this analysis while taking 
into account the severity of asthma.  
Strengths of this research include the use of large representative samples of the 
population, and the focus on adolescents and young adults, which are usually under-represented 
in epidemiologic research. The longitudinal analyses, use of sleep duration trajectories, and the 
novel questions that were addressed in this research are among the major strenghths. 
Our future research plans include a follow-up study using wave V of the Add health 
study, currently under collection, to examine the effects of sleep duration trajectories on the risk 
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of asthma by age 32-40, and the potential mediation by hs-CRP levels in wave IV (age 24-32) 
(figure B.1). We will also examine the effects of sleep duration trajectories in males and females 
on the change in hs-CRP levels between waves IV and V.  
The results of this study have significant public health implications. Given the increase in 
the incidence and prevalence of asthma, and given the progressive decrease in average sleep 
duration in adolescents, it is likely that behavior-modification interventions that aim at increasing 
sleep durations in adolescents will have a significant impact on the incidence and prevalence of 
asthma, along with the associated morbidity, mortality, and economic burden. 
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APPENDIX A 
REVIEW OF CURRENT LITERATURE 
 
ASTHMA 
Asthma is one of the most common chronic diseases in children and adults worldwide and 
is the most common chronic diseases in childhood, affecting 7 million children in the US.4 Asthma 
is an inflammatory lung disease, with a complex pathophysiology that involves airway 
inflammation, intermittent airflow obstruction, and bronchial hyperresponsiveness. It is 
characterized by episodes of airway obstruction leading to symptoms of cough, wheezing, 
shortness of breath, and chest tightness.86 There are two general types of asthma: Allergic and non-
allergic (or atopic and non-atopic),87 which differ little in terms of manifestations, but have 
different risk factors and triggers.88  
The prevalence of asthma has been increasing in recent years, at a rate of 1.5% per year, to 
a prevalence of 8.4% in 2010, and the number of persons with asthma has increased between 2001 
and 2010 by 2.9% each year, from 20.3 million persons in 2001 to 25.7 million persons in 2010. 
Current asthma prevalence is higher in children than in adults, and in females than in males.3 
According to findings from the Asthma Call Back Survey (2006-2008), incidence among youth 
aged 12-17 years was 4.4/1000 and in adults 3.8/1000. 89. 
Asthma is a significant cause of morbidity and mortality, leading to an estimated 14.4 
million lost school days in children and 14.2 million lost workdays in adults in 2008.90  Asthma is 
also a leading cause of activity limitation and costs our nation $56.0 billion in health care costs 
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annually.90 The death rate per 1,000 persons with asthma was 0.15 for the period of 2007–2009, 
and it is more than 30% higher for females than males, 75% higher for black persons than it is for 
white persons, and almost seven times higher for adults than children. 1 
Risk factors for asthma include family history and prenatal risk factors such as maternal 
smoking, diet and nutrition, and delivery by cesarean section. Childhood risk factors for asthma 
may include allergic sensitization, environmental tobacco smoke, obesity, gastroesophageal 
reflux; decreased lung function in infancy; family size and structure; socio-economic status; 
antibiotics; and infections, while breastfeeding may have a protective effect against the 
development of asthma. Occupational exposures, smoking, and obesity constitute common risk 
factors for adult asthma. Triggers of asthma exacerbations commonly include infections, exposure 
to allergens or other irritants, exercise, and stress 52 
Obesity and asthma. The prevalence of obesity has been on the rise in USA for the past 
decades, from 23.0% of adults in 1988–1994 to approximately 36.0% in 2009–2010.91 Similarly, 
the prevalence of obesity in adolescents aged 12-19 increased from 5% in 1980 to nearly 21% in 
2012.92 Obesity is a risk factor for many chronic diseases including cardiovascular disease, 
diabetes, stroke, and sleep apnea.92 The association between obesity and asthma has been studied 
extensively, with many studies finding an increased risk of asthma in obese children and adults.5,93–
96 Obesity is also associated with poor asthma control and quality of life, and more asthma-related 
hospitalizations.97–99 However, these associations may be modified by gender. Kattan et al.100 
found that increased BMI in female adolescents was associated with worse asthma control, more 
exacerbations, and worse pulmonary function, while these effects were not observed in males. On 
the other hand, adiponectin had a protective effect in males but not in females.100  
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Several mechanisms were proposed to explain association between obesity and asthma 
including cardio-respiratory deconditioning, physiological restriction of the chest wall by excess 
adipose tissue, common genetic predisposition, and co-morbidities such as gastroesophageal reflux 
disease and sleep disordered breathing (SDB).93 Additionally, the inflammatory pathway is now 
considered a plausible explanation, given that obesity is associated with chronic low grade 
systemic inflammation.101 In particular, Leptin (a proinflammatory adipokine) and adiponectin (an 
anti-inflammatory adipokine) were the focus of many research studies.100,102–104  Leptin, which is 
markedly increased in obesity,93 may play a role in asthmatic inflammation and may be a key 
modulator of airway remodeling.93,103 Leptin increases production of Tumor Necrosis Factor 
(TNF)-alpha, and Interleukin 6 (IL 6), both of which are increased in asthma.103,105 The role of 
gender in the association between Leptin and asthma in not clear. Abdul Wahab et al.93 found that 
higher Leptin levels were strongly associated with female gender in asthmatic children.93 By 
contrast, Guler et al. found the difference in Leptin concentration to be confined to boys.103 
Another marker of systemic inflammation in C-Reactive Protein (CRP), Which is found to 
be elevated in individuals with asthma and negatively correlated with pulmonary function 
indices.106–108 High sensitivity CRP (hs-CRP) is also correlated with the numbers of sputum 
eosinophils,107 suggesting that serum hs-CRP can indirectly indicate the degree of airway 
inflammation. However, studies of the role of hs-CRP in the association between obesity and 
asthma have been inconsistent. Several studies found that hs-CRP is more elevated in obese 
asthmatics compared with non-obese asthmatics.94,100,104,109 Additionally, a study by Michelson et 
al. even showed that some of the seeming association between obesity and asthma is significantly 
mitigated after controlling for serum CRP levels.7 By contrast, a study by Bekkers et al. concluded 
that hs-CRP did not play a role in the association between BMI and asthma symptoms,96 and Huang 
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et al. found no significant difference in CRP levels between obese and non-obese asthmatics.110 
Although the latter study was limited by its sample size. Furthermore, studies conducted by Kattan 
et al., Bekkers et al., and Dixon et al. revealed that hs-CRP levels did not correlate with asthma 
severity or symptoms in obese individuals.96,100,111  The discrepancy in results is likely due to the 
existence of a distinct obesity-related phenotype of asthma, which is different from atopic 
asthma.101 Obese asthma is likely to be the result of mechanical restriction of breathing, and is not 
associated with increased airway or systemic inflammation (measured by exhaled nitric oxide, 
sputum eosinophils, blood CRP, and IL-6).54 However, obesity itself is associated with systemic 
inflammation and may increase the risk of atopic or non-atopic asthma through different 
pathways.54 The variability in prevalence of each phenotype in different study populations may 
explain the difference in results. 
 Concerning the effect of obesity on airway inflammation, animal studies as well as some 
observational ones suggested that obesity- induced systemic inflammation might influence 
pulmonary inflammatory mechanisms.6,93,103 However, other studies failed to find a link between 
obesity and markers of airway inflammation such as exhaled Nitric Oxide (eNo), and sputum 
eosinophils in asthmatic subjects,5,94,112  while BMI was found to be associated with eNo in healthy 
individuals.113 These two markers are usually elevated in atopic asthma, which may indicate that 
obesity is associated with non-atopic asthma only, or that asthma in obese individuals is a separate 
phenotype that needs special treatment considerations. The association between obesity and 
asthma is complex and multifactorial, and cannot be explained by inflammation alone.  
 Systemic inflammation and asthma. A few longitudinal studies examined the link 
between systemic inflammation and subsequent asthma. Ahmadi-Abhari and colleagues conducted 
a longitudinal study that included 18,110 men and women aged 40–79 years.114 Results of the 
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study revealed that a 1-standard deviation increase in loge-CRP over 13 years was associated with 
a decline in FEV1 (−64.0 mL ,95% C.I.: −72.1, −55.8)  and a decline in FVC over the same period, 
regardless of baseline CRP. Similarly, Shaaban et al. found an inverse association between change 
in CRP and change in FEV1 over time, while no association was found between baseline FEV1 
and subsequent change in CRP.115 Furthermore, Fogarty et al. and Hancox et al. also found serum 
CRP levels to be inversely related to FEV1 and FVC. However, they found no significance 
association between baseline CRP and rate of decline in lung function in young adults.116,117 By 
contrast, Rasmussen et al. conducted a study of 1,134 young adults aged 20 years and found lower 
pulmonary function indices at age 29 and a greater decline in FEV1 and FVC in persons with 
higher baseline CRP, as well as with the increase in CRP between the ages of 20 and 29.54 
Similarly, in the Coronary Artery Risk Development in Young Adults (CARDIA) Study Kalhan 
et al. found a greater decline in FVC and FEV1 in young adults with higher baseline CRP.118  These 
studies indicate that systemic inflammation has a negative impact on lung function in healthy 
young adults, which raises the question of its impact on the lung function of asthmatics. 
 Adolescents and young adults with asthma are a unique population, given the physical 
and psychological changes that occur during this period and affect the health and well-being of 
teenagers.27 Adolescents are at increased risk of asthma morbidity and mortality as a result of their 
new independence and the shift in responsibility for asthma management from parents to 
adolescents. Non-adherence to treatment, lifestyle factors, and comorbid depression are among the 
contributing factors to increased morbidity.27 Similarly, young adults may be uninsured and lack 
access to health care as they transition from pediatric to adult health care, which puts them at risk 
for poor asthma control. They also frequently have unhealthy life styles that negatively affect their 
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asthma, and are prone to non-compliance with their maintenance medications.119 Yet, few asthma 
research studies include these age groups.  
SLEEP DISORDERS AND THEIR CONSEQUENCES                  
 Sleep is a fundamental human need, yet the quantity and quality of sleep in modern society 
have been declining steadily for the past decades. A 1994 Report of the National Commission on 
Sleep Disorders Research estimated that total sleep time for the US population has decreased by 
20% over the past century.28 This reduction is related to the availability of electric lighting as well 
as other changes in environmental and social conditions, such as extended shift work and round-
the-clock activities.53. Disorders of sleep and wakefulness are widespread in modern society; with 
an estimated 50 to 70 million Americans suffering from one or more of over 90 distinct sleep 
disorders,53 which may result in an annual cost of $16 billion in health care and $50 billion in lost 
productivity.9 Symptoms of most sleep disorders include excessive daytime sleepiness, difficulty 
initiating or maintaining sleep, and abnormal events occurring during sleep. These disorders affect 
daily functioning and can adversely affect health and longevity.53 
 Sleep loss in adults generally refers to sleep of shorter duration than the average basal need 
of 7 to 8 hours per night. Sleep loss is a prevalent problem with at least 18% of adults reporting 
insufficient sleep.120 Adolescents also frequently report insufficient sleep, with half of high school 
students participating in the 2007 National Youth Risk Behavior Survey reporting short sleep 
duration (6-7 hours per night), and another 14.8% of males and 16.9% of females reporting very 
short sleep durations (5 hours or less).29 Contrary to popular belief, adolescents need as much sleep 
as pre-teens, with an optimal sleep duration of about 9 hours per night.121  
 Insomnia is the most commonly reported sleep disorder, which affects approximately 10 
per cent of US adults. It is defined as “difficulty falling asleep, difficulty maintaining sleep, or by 
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short sleep duration despite adequate opportunity for a full night’s sleep”.53 The prevalence of 
insomnia is higher in women and it increases with age in both sexes.122 
 Sleep loss is associated with many deleterious health consequences such as obesity, 
diabetes and impaired glucose tolerance, cardiovascular disease and hypertension, anxiety 
symptoms, depressed mood, and alcohol use.123 These associations were mostly observed in 
observational studies, many of which are cross-sectional, therefore we cannot make assumptions 
of causality. Some of these diseases may be the cause of sleep loss, rather than the inverse.  
 A number of possible biological mechanisms were proposed to explain the between sleep 
loss and obesity. These mechanisms include neuroendocrine changes; chronic inflammation; and 
hormonal changes that result from loss of sleep.53 An experimental case-crossover study by 
Spiegel et al. found that sleep loss is associated with a decrease in Leptin and an increase in 
Ghrelin, both are appetite-regulating hormones, leading to increased subjective hunger and a 
greater desire for calorie-dense foods.124 Similarly, Boeke et al. found shorter sleep duration to be 
associated with lower levels of leptin in young girls and in male adolescents, suggesting a sex-
specific effect.125 However, the Nurse’s Health Study suggested that the association between sleep 
loss and weight gain is not necessarily due to an increase in appetite, but rather due to changes in 
energy metabolism.8 Furthermore, a review by Knutson et al, suggested that sleep problems may 
be associated with reduced energy expenditure, which may explain the increased risk of obesity.126 
  Dysregulated inflammatory mechanisms may occur as a result of primary sleep disorders 
such as insomnia and obstructive sleep apnea, manifesting as an increase in serum pro-
inflammatory C-reactive protein; IL-6; and TNF-α.53 Moreover, experimental studies found that 
acute sleep deprivation resulted in an increase un IL-6 and/or hs-CRP.127–130 However, 
observational studies on the association between chronic sleep loss and systemic inflammation had 
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inconsistent results. Martinez-Gomez et al. found short sleep to be associated with an elevated 
CRP in adolescent.69 By contrast, Taheri et al found no association between short sleep duration 
and CRP levels in adult men and women participating in the Wisconsin Sleep Cohort Study,131 
while Okun et al. found that poor sleep quality, but not duration, was associated with an increase 
in hs-CRP.76 On the other hand, a number of studies (Suarez et al.79 as well as  Miller et al.77 and 
Liu et al.120) found an association between sleep duration and hs-CRP that is limited to women, 
which suggests that Taheri’s insignificant results may be due to an insufficient number of women 
in the study. By contrast, Liukkonen found an association between sleep disturbances and CRP 
that is significant in men but not in women.80 This latter study was cross-sectional and included 
premenopausal women at the age of 31. By contrast, the studies by Liu et al. and Miller et al. 
included a population with an average age of 48 years, which includes pre- and post-menopausal 
women. Hormonal changes may explain the discrepancy in results of these studies. Longitudinal 
studies included the one conducted by Ferrie et al.,70 which found that each hour per night decrease 
in sleep duration between 1991/1994 and 1997/1999 was associated with higher levels of C-
reactive protein (8.1%) and interleukin-6 (4.5%). However, the association with CRP was no 
longer significant after adjustment for cardiometabolic risk factors (hypertension, BMI, 
cholesterol, and diabetes), while IL6 remained significant. Patel et al also found a significant linear 
association between sleep duration and both hs-CRP and IL6, where each additional hour of sleep 
led to an 8% increase in CRP and 7% increase in IL6.74 Whereas Miller et al. found no trend, linear 
or non-linear, between sleep duration and IL-6. They did however, find that levels of IL-6 were 
lower in women with longer sleep duration (8 hours compared with 7 hours).77 Furthermore, Dowd 
et al. found that longer sleep duration (more than 8 hours) was associated with elevated levels of 
CRP and IL-6.72 Grandner et al.71 also found extreme sleep durations (very short and very long) to 
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be associated with elevated CRP. However, similar to the study by Ferrie et al.,70 the association 
between short sleep and CRP was no longer significance after adjusting for comorbid illnesses and 
concurrent sleep disorders. By contrast, long sleep duration remained significant in all models.71 
This U-shaped association between sleep duration and inflammatory markers mirrors that of sleep 
duration and mortality, where both short and long sleep durations were associated with higher risk 
of death,73,132,133 suggesting that there is an optimum duration of sleep that is associated with good 
health and well-being.  
 Persistent inflammation is associated with many diseases, such as Type 2 diabetes, 
cardiovascular disease and asthma.134 Inflammatory mechanisms contribute to the association 
between sleep loss and many chronic illnesses.135 Yet, there is still considerable uncertainty as to 
whether sleep duration is simply an associated risk marker or a causal risk factor in any disease 
process.11 The discrepancy in results is likely to be due to variability in defining sleep quality and 
categorizing sleep duration, which makes different studies difficult to compare or generalize. 
 Insufficient sleep in adolescents has been linked to depression, anxiety, inattention and 
conduct problems, drug and alcohol use, impaired academic performance, and suicidal thoughts 
and behaviors.121 Adolescent short sleepers have also been reported to have more fatigue, less 
energy, worse perceived health and symptoms such as headaches; stomachaches and backaches, 
and more respiratory infections.121,136 Similarly, college students and young adults frequently 
suffer from poor sleep quality and insufficient sleep.137 Lund et al. reported that nearly 60% of 
college students have of poor sleep quality and frequently depend on alcohol and medications to 
manage their sleep.138 Sleep deprivation has negative effects on cognitive performance in young 
adults,137 and is associated with drug and alcohol use, depression, and obesity,139 among other 
negative health consequences.  
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SLEEP AND ASTHMA 
 Sleep disturbances in asthma: Asthma is frequently associated with poor sleep 
quality, thought to be mainly due to nocturnal symptoms experienced at least once a month by 
as many as 74% of asthmatics.30 Nocturnal worsening of asthma symptoms occur as a result 
of circadian rhythms of circulating hormones (such as epinephrine, cortisol, and melatonin),140 
sleep-related variation in airway caliber,141 and the increase in upper airway resistance, 
especially in those with uncontrolled asthma.142–144 Nocturnal asthma is marked by a decrease 
in FEV1 of at least 15% between sleep onset and wake up time in asthmatic patients.94 In 
addition to variation in FEV1, the airways become hyper-reactive and under-responsive to 
bronchodilators during sleep in individuals who have nocturnal asthma.13 Consequently, 
asthmatics have more frequent sleep disturbances, including difficulty initiating and 
maintaining sleep, and shorter sleep duration.34,55 Asthmatic children and adults were also 
found to have longer sleep latency32,35,145,146 and reduced duration of sleep.34,35 However 
Jansen et al found the increase in sleep latency to be limited to females, suggesting gender -
related differences. 
 In addition to nocturnal symptoms, medications used to treat asthma may have a role in 
some sleep disturbances. Bronchodilators (beta-agonists) act as stimulants and may cause sleep 
disturbances when given in high doses, corticosteroids in high doses decrease slow wave sleep and 
REM sleep, and Aminophylline decreases sleep efficiency and REM sleep and increases sleep 
latency.55 However, Garrison et al reported that controller medications, especially leukotriene 
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inhibitors, might be effective in reducing sleep problems through their effect in controlling 
symptoms.147  
 Nocturnal symptoms and medications do not fully explain sleep disturbances in asthmatics. 
Even clinically stable asthmatics appear to have more frequent sleep disturbances.11,42 In a study 
by Luyster et al, the majority (88–100%) of participants with non-severe asthma (NSA) or severe 
asthma (SA), who did not report nighttime asthma disturbances, still reported having poor sleep 
quality.148 In both asthma categories, poor sleep quality was associated with worse asthma control 
and quality of life after controlling for GERD and other covariates.148 Similarly, in a study of 
asthmatic adults by Mastronarde et al., Global Pittsburgh Sleep Quality Index (PSQI) scores 
correlated with asthma control, quality of life, and marginally with FEV1%, but Epworth 
Sleepiness Scale (ESS) did not correlate with FEV1% or with asthma control. Furthermore, neither 
PSQI nor ESS were associated with asthma exacerbations, and neither were affected by treatment 
with theophylline or Montelukast.14 Moreover, Stores et al. conducted a study of asthmatic 
children using Polysomnography, and found that children with asthma had more sleep disruption, 
nighttime awakenings, and reduced sleep efficiency, than non-asthmatic children, although actual 
sleep time and REM/NREM sleep did not differ between asthmatics and non-asthmatics. 
Additionally, subjective impairment and daytime sleepiness were much higher in asthmatic 
children.36 Furthermore, a study by Chugh et al that included 40 children with clinically stable 
asthma and 30 age and gender matched, healthy children, children with asthma were found to have 
significantly worse quality of sleep and longer sleep latency.42  
 Sleep duration and asthma: Several studies showed that sleep duration is generally 
shorter in children and adults with asthma. In a community- based study of 1,478 subjects, those 
with asthma had a higher prevalence of ‘too little sleep’ (39% compared with 29% for non-
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asthmatics) and a higher risk (OR=2) of unrefreshing sleep, after adjusting for age, gender, and 
snoring.145 Similarly, two studies by Janson et al. and Vir et al. using sleep diaries, also found that 
asthmatics recorded shorter sleep time compared with controls.32,33 Interestingly, a study of 
children 5-17 years of age using polysomnography, found that male asthmatics had significantly 
shorter sleep duration (425.9 (5.4) vs 441.8 (5.4) min, p < 0.05) than male controls, while females 
did not display a significant difference.35 By contrast, in the study by Stores et al. mentioned 
earlier, using Polysomnography, actual sleep time did not differ significantly between children 
with asthma and their healthy counterparts.36 However, the study had a small sample size (15 
children, aged 6-15) that may have been responsible for the non-significant results. Furthermore, 
Desager et al, using a sleep questionnaire completed by parents, did not find a significant 
difference in total sleep time between asthmatic and non-asthmatic schoolchildren, while they did 
find significant differences in nocturnal awakenings, restless sleep, daytime sleepiness, and 
tiredness.37 Similarly, Meltzer et al., found no significant difference in sleep duration between 
asthmatic and non-asthmatic adolescents, using an online survey completed by the adolescent.22 
However, more adolescents with severe asthma reported insufficient weekday sleep (44%) versus 
adolescents without asthma (31%).22 Moreover, a study of adults by Teodoruscu et al. suggested 
that the association between sleep duration and asthma might be related to asthma severity, as they 
found that sleep duration was inversely associated with the severity of asthma. Interestingly, a 
case-control study by Chugh et al. found that children with clinically stable asthma slept longer on 
average than healthy controls, despite having poorer sleep quality.42  
 The studies cited above used different study designs, assessment instruments, and age 
groups, which may explain the discrepancy in results. Using subjective versus objective measures 
of sleep duration may cause systematic bias133 that makes these studies incomparable. In addition, 
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questionnaires completed by parents of adolescents (like the study by Desager et al. mentioned 
above) may not accurately reflect sleep duration, as parents tend to report earlier bed times and 
give an idealized version of their adolescents’ sleep habits.38 
 The impact of sleep quality on patients with asthma: While there are many studies of 
the impact of asthma on sleep quality, studies exploring the reverse are very limited. Most of those 
who examined the impact of sleep quality looked at quality of life and daily functioning as the 
outcomes of interest. For example, Daniel et al. studied the association between missed sleep and 
asthma morbidity in children, and found that higher reports of missed sleep were associated with 
more frequent school absences, more activity limitations, and lower quality of life scores.18 Diette 
et al. found that children who awoke from asthma had greater odds of missed school days, 
compared with those who did not awake, with the odds being higher with awakenings that are 
more frequent. In addition, parents of children who awoke from asthma also had higher odds of 
missing work, indicating that quality of life of both children and parents was affected by nocturnal 
symptoms.19 Furthermore, during a 6-month prospective clinical trial, Mastronade et al. found that 
improved PSQI and Epworth Sleepiness Scale (ESS) scores correlated with improvements in 
asthma control and Asthma-related Quality Of Life (AQOL).14 Moreover, Matheson et al. studied 
quality of life in people with asthma or wheezing, and found that wheezing in the past 12 months 
was associated with decreased quality of life, while having current asthma, or a doctor’s diagnosis 
of asthma, were not significantly associated with QOL. The authors’ conclusion was that 
symptoms, not the epidemiological definition of asthma, are what affects quality of life.20 
Similarly, in a cross-sectional study of college students with asthma, Molzon et al. found that 
poorer sleep quality in asthmatic college students was related to lower HRQOL.21 However, as the 
authors pointed out, the cross-sectional design of this study does not permit the conclusion of 
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causality. The above-mentioned studies indicate that quality of sleep affects quality of life in 
asthmatics, and that nocturnal symptoms are the most likely cause for sleep disruption.  
 As for the effect of sleep quality on asthma control and severity, a few studies suggested 
that the association between sleep and asthma might be bi-directional. In a study conducted by 
Becker et al. and presented at the European Respiratory Society Annual Congress 2013, the authors 
examined the association between sleep and asthma outcomes, and concluded that there is 
probably a bidirectional relation between asthma control and poor quality of sleep. However, the 
associations were marginally significant.15 In a study of 38 youth with asthma (aged 9-19), Hanson 
and colleagues found that poorer self-reported sleep quality predicted more severe symptoms, 
lower cortisol output, and lower PEF% the next day, while PEF and symptoms did not predict 
sleep quality or quantity the next night. The results suggest that sleep may affect subsequent health 
outcomes, rather than asthma affecting subsequent sleep.16 Despite the small sample size, this 
study offers a very important indication of the effect of sleep on asthma symptoms and pulmonary 
function, as well as the role of cortisol. Furthermore, in a review sleep abnormalities and chronic 
inflammatory conditions, Ranjbaran et al. concluded that “sleep disturbances are one of the major 
modifiers of asthma that can affect the course and the severity of the disease”. The mechanisms 
they cited included physiologic changes as a result of sleep disturbances that adversely affect 
respiration, arousal responses, and airway clearance of asthmatics.144 Similarly, Diette and 
colleagues found that children who experienced nocturnal awakenings had increased symptom 
severity, and an increased use of reliever medications.19  
 Experimental evidence supporting the impact of sleep on asthma came from a recent pilot 
study by Meltzer et al.22 This pilot sleep-extension study included 12 teens with asthma, and found 
that teenagers who got more sleep during the 2-week program had significantly fewer nocturnal 
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asthma symptoms (P=0.001) and less variability in objective daily lung function (P=0.05). The 
authors explained the findings by the decrease in inflammation as a result of increased sleep 
duration, which in turn improved asthma expression.22 Further evidence came from a 6-month 
prospective clinical trial by Mastronarde et al, who found a correlation between asthma control 
scores (and marginally FEV1%) and global Pittsburgh Sleep Quality Index (PSQI). Moreover, 
they found that the improvement in PSQI and Epworth Sleepiness Scale (ESS) scores during the 
study period correlated with improvements in asthma control and Asthma-related Quality Of Life 
(AQOL), even in individuals who have no history of nocturnal awakenings.14 This study was 
limited to adult (mean age 40±15 years), who had mild-moderate symptomatic asthma. 
 A few longitudinal studies provided further clues into the effect of sleep disturbances on 
asthma morbidity. Leander et al. conducted a 13-year longitudinal study of 391 adolescents and 
adults, and found that those who developed asthma during the study period were more likely to 
have had sleep disturbances at baseline (30% vs. 10%).23 Furthermore, Kozyrskij et al followed 
2398 children from birth until age 14, and found that persistent nocturnal awakening in early life 
was associated with an increased risk of non-atopic asthma at age 6 and 14 (at age 14 years: OR 
2.18, 95% CI 1.15–4.13).24 This study provides the strongest evidence to date of the association 
between sleep disturbances and the development of non-atopic asthma. On the other hand, Zhang 
et al. studied 1534 Chinese adolescent twins age 12–21 years and found a dose-response 
relationship between sleep duration and sensitization to food and aeroallergens. Twins with shorter 
sleep durations were more likely to be sensitized to food and aeroallergens than those in the highest 
tertile of sleep.25 Although they did not study asthma as an outcome, the association between 
sensitization (especially to aeroallergens) and asthma is well-established,149 therefore, this study 
provides further evidence into an (probably indirect) association between sleep duration and 
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asthma. Likewise, Jernelov et al. studied 1480 twin pairs and found that being overtired at age 8 
was associated with an increased risk of allergic rhinitis and asthma at age 13. However, the 
association with asthma was no longer significant after controlling for the presence of asthma at 
age 8, while allergic rhinitis remained significant. However, short sleep at age 8 was not associated 
with allergic rhinitis or asthma at age 13.26 Unlike Zhang et al., the authors of this study did not 
measure sleep duration. They used parental perception instead, with a question that states, “Child 
sleep less than other kids”, with answers of “often true, sometimes true, not true”. This question 
does not measure sleep duration accurately, which makes the comparison with other studies very 
difficult. The studies mentioned above used different age groups and different measure of sleep, 
which explains the discrepancy in some of their results.                                                                                                  
       Possible Mechanisms: Many mechanisms have been suggested to explain the impact of 
sleep disturbances on the development as well as the morbidity of asthma. These mechanisms 
include: 
1. Comorbid conditions: Certain comorbid conditions that are associated with sleep 
disturbances as well as poor asthma outcomes were thought to explain the sleep-asthma 
association at least partially. These conditions also interact with one another as shown in Figure 
1. They include:  (1) Obesity, which is known to be associated with both asthma150 and short 
sleep duration,151 although the mechanisms of these associations are not clear. It is possible that 
short sleep duration leads to an increase in BMI, which in turn is associated with increased 
airway inflammation and worse asthma morbidity.105 However, some studies showed an 
association between sleep duration and asthma that is independent of BMI, indicating that BMI 
cannot entirely explain the sleep-asthma association,35,37,42 although it can exacerbate sleep 
problems in asthmatics. Furthermore, many asthmatics have normal BMI, including those who 
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have less than optimal sleep duration. (2) Obstructive sleep apnea (OSA) is another comorbid 
condition associated with both sleep and asthma.146,152 OSA is strongly associated with obesity, 
and often leads to sleep disruption and daytime sleepiness, as well as increased systemic and 
airway inflammation.153,154 However, OSA is not usually associated with shorter duration of 
sleep; therefore, it does not explain the association between sleep duration and asthma. It is 
possible though, that the combined effect of OSA and short sleep duration may lead to poorer 
asthma outcomes.155 (3) Allergic rhinitis (AR) is significantly associated with atopic asthma and 
with impaired quality of sleep.152 The strong correlation between asthma and AR makes it 
difficult to study the association between sleep and asthma, independent of allergic rhinitis. 
Furthermore, the disease processes in AR and asthma are very similar; therefore, AR needs to be 
taken into consideration when studying asthma as an outcome. (4) Gastroesophageal reflux 
disease (GERD) aggravates asthma and is associated with poor sleep quality.105 However, sleep 
duration is not usually affected by GERD. Furthermore, Luyster et al. found that poor sleep was 
associated with worse asthma control, independent of GERD.148 Additionally, there is no 
evidence that GERD treatment improves nocturnal asthma or asthma control.13 (5) Depression 
and anxiety are both associated with sleep disturbances as well as asthma severity. A study based 
on the Israeli health survey found that depressive symptoms were common in asthmatic 
individuals and were associated with less hours of sleep.156 Similarly, a study of US adults, based 
on the 2006 Behavioral Risk Factor Surveillance System (BRFSS), found that asthmatic adults 
who have current depression were more likely than those without current depression to report 
insufficient sleep, in addition to other HRQOL measures157 The mechanism of these association  
may lie in the hormonal pathway (see below). Depression, anxiety, and stress are likely to be 
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contributing factors to the sleep-asthma association. However, they may be the cause of 
insufficient sleep, or may also occur as a result of the sleep disturbances.        
 2. Hormonal pathways: Sleep restriction affects the hypothalamic pituitary adrenocortical 
(HPA) axis, which leads to an increase in secretion of the stress hormone, Cortisol. As mentioned 
above, Ising&Ising found that sleep disruption as a result of traffic noise leads to an increase in 
cortisol secretion in the first half of the night and a disruption in circadian rhythm of cortisol 
secretion. They suggested that this disruption is associated with an aggravation in bronchitis and 
asthma in children.158,159 By contrast, Hanson et al. studied 38 youth with asthma (age 9-19) and 
found that greater reported sleep quantity predicted lower cortisol output and lower PEF% the 
following day.16 Similarly, Capaldi et al. conducted a pilot study of the association between sleep 
and cortisol responses to stress in children and adolescents, and found that greater sleep-wake  
 
behavior problems were associated with decreased cortisol responses, while no association was 
found between sleep quantity and cortisol.160 Although the authors did not study the impact on 
asthmatics, the study provides evidence of the effect of sleep disruption on cortisol secretion. The 
Figure A.1: Asthma and comorbid 
conditions. 
 Source: Catherine Kier, Stephanie 
Hom, and Faiza Qureshi (2012). 
Asthma and Sleep. Journal of Asthma 
& Allergy Educators. Vol 3:No. 3, pp: 
99-105 
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association between cortisol levels and asthma is further clarified through studies by Priftis et 
al.,161 Buske-Kirchbaum et al.,162 and Wamboldt at al.,163 which showed that children with asthma 
have an attenuated cortisol response to stress. Priftis et al. suggested a model that explains the 
pathway through which stress may influence asthma in children. Stress leads to an increase in 
proinflammatory cytokines, which in turn attenuate cortisol response, leading to airway 
hyperactivity and inflammation.161 This points out to the possibility that poor sleep quality and 
insufficient sleep alters cortisol response to stress as suggested by Capaldi, leading to an increase 
in airway inflammation and asthma exacerbations through the mechanism suggested by Priftis.  
 3. Effect on the immune system: Another mechanism through which sleep deprivation 
can affect asthma is through its alteration of the immune response to a viral illnesses,164,165 and 
increased susceptibility to infections and allergy.165 Orzech et al. found that adolescents with 
shorter sleep time suffered more frequent bouts of acute infections.166 Viral infections are common 
triggers of asthma exacerbations; mostly due to inflammation that accompanies these infections.17 
Therefore, susceptibility to infections because of sleep deprivation can have a negative impact on 
asthma.167 
 4. Inflammation: As mentioned above, sleep loss is associated with systemic 
inflammation,8 which in turn was found to be associated with asthma severity in cross-sectional 
analyses.7,106–108 Furthermore, Kalhan et al. and Ahmadi-Abhari et al. found that systemic 
inflammation is longitudinally associated with a decline in lung function, with a potential negative 
effect on asthmatics.114,118 In the CARDIA study of healthy young adults, Kalhan et al. found that 
higher CRP in year 7 was associated with greater 15-year decline in both FVC and FEV1.118 
Similarly, Ahamadi-Abhari and colleagues studied the longitudinal association between CRP and 
lung function over a 13-year period. They found that a one SD increase in baseline loge-CRP was 
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associated with a reduction in FEV1 (-86.3 mL, 95% CI: -93.9, -78.6). In addition, a one SD 
increase in log-CRP over 13 years was associated with a decline in FEV1 over the same period (-
64.0 mL, 95%CI: -72.1, -55.8).114 These findings may explain the association between sleep 
disturbances and asthma through the inflammatory pathway. Furthermore, Majde and Krueger 
conducted a review of the link between the innate immune system and sleep, and concluded that 
the role inflammatory cytokines play in asthma partially explains why sleep disorders exacerbate 
asthma.17 Moreover, Axelsson et al. found that sleep restriction results in a shift of the immune 
system toward the response of helper T cells, type Th2, which are associated with allergic diseases 
and asthma.167Additionally, sleep disturbances are associated with an increase in IL-8 and TNF-α. 
The latter has been implicated in asthma exacerbations;101 airway inflammation associated with 
severe asthma in adults; and was also found to be elevated in children with viral wheeze or 
bronchial hyperactivity.24  
 Sleep deprivation is also associated with airway inflammation, manifesting by elevated 
FeNO. Malish et al. found that medical residents who engaged in regular in house calls, leading to 
sleep deprivation had elevated FeNo levels compared with their non-call counterparts.168 Similarly, 
Oberg et al. found that male medical residents had higher FeNo levels when post-call than when 
not on-call.169 These studies point to the effect of sleep loss in young healthy individuals on airway 
inflammation, which raises the question of the effect would be even more pronounced in asthma 
patients, and what impact it would have on their symptoms.  
 SUMMARY 
 The literature review presented above highlights several gaps and issues that limit our 
understanding of the association between sleep duration and asthma. Very few studies attempted 
to examine this association, and most of those had very small sample sizes, or were limited to the 
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examination of quality of life in asthmatics. Longitudinal studies mostly examined the risk of 
allergic sensitization in children, rather than measures of asthma morbidity. Studies of adolescents 
and young adults are severely lacking, as are studies of the role of the interactions of sleep duration, 
asthma, and gender and their association with inflammation. There is a need for adequately 
powered studies that examine the association between sleep duration and asthma morbidity in 
adolescents and young adults, while accounting for the role of inflammation.  
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APPENDIX B 
ADDITIONAL TABLES AND FIGURES 
 
 
Figure B.1: Add Health study design  
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Tables B.1: Sleep duration statistics by trajectory group in participants of waves 3 & 4 of 
the Add Health study  
 
TRAJECTORY GROUP WAVE 3 MEAN SLEEP 
DURATION (95% CI) 
WAVE 4 MEAN SLEEP 
DURATION (95% CI) 
GROUP 1 5.47 (5.3-5.6) 5.75 (5.6-5.9) 
GROUP 2 7.95 (7.9 – 8.0) 7.82 (7.79 – 7.86) 
GROUP 3 10.7 (10.4- 11.0) 10.6 (10.2 – 10.7) 
 
 
Table B.2: Results of multivariate linear regression analysis for natural logarithm of CRP 
and sleep duration in waves 3 & 4 in the Add Health study (Regression coefficients and P-
values), after including CRP values greater than 10 mg/l 
§ Fully adjusted model included sex, race, income, education, smoking, alcohol, physical activity, trouble 
sleeping, snoring, hypertension, depression, symptoms of infection, subclinical symptoms of inflammatory 
disease, & medication use 
 
 
 
 
 
Table B.3: Association between sleep in waves 3 & 4 and CRP levels greater than 3 mg/dl in 
the Add Health study (Odds ratios and 95% C.I.) after includin CRP values > 10 mg/l 
 Unadjusted Fully adjusted 
Sleep duration trajectory group 
 Short 
 Good 
 Long 
 
1.41 (1.09, 1.82) 
 Ref 
1.23 (0.85, 1.80) 
 
1.74 (1.26, 2.38) 
Ref 
1.14 ( 0.64, 2.03) 
§ Fully adjusted model included sex, race, income, education, smoking, alcohol, physical activity, trouble 
sleeping, snoring, hypertension, depression, symptoms of infection, subclinical symptoms of 
inflammatory disease, & medication use 
 UNADJUSTED 
COEFFICIENT (P-VALUE) 
FULLY ADJUSTED§ 
Sleep duration  trajectory group 
 Short 
 Good 
 Long 
 
0.065 (0.1539) 
Ref 
0.151 (0.0735) 
 
0.091 (0.0492) 
Ref 
0.109 (0.1837) 
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